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A leishmaniose visceral (LV) é uma doença infeciosa causada por 
algumas espécies do género Leishmania (L. infantum e L. donovani) 
que se revela particularmente problemática nas regiões tropicais e 
subtropicais. Uma vez no hospedeiro, os parasitas apresentam um 
grande tropismo para os macrófagos subvertendo as funções 
imunomoduladoras destas células. O estudo destes mecanismos de 
subversão foi durante largos anos focado na modulação a nível 
proteico, sendo dada pouca relevância ao efeito dos parasitas no perfil 
lipídico dos macrófagos. No entanto, devido ao crescente 
conhecimento acerca das funções imunomoduladoras dos lípidos, 
estes podem ser vistos como alvos terapêuticos promissores para o 
tratamento da leishmaniose. Deste modo, o objetivo geral deste 
trabalho consistiu na análise do perfil lipídico de macrófagos 
infectados com Leismania infantum, usando uma abordagem 
lipidómica, de modo a elucidar a contribuição de mudanças induzidas 
na patogénese da infeção. As diferentes classes de fosfolípidos foram 
separadas por TLC e quantificadas por através de um ensaio de 
fósforo e os ácidos gordos analisados por GC-FID. O extrato lipídico 
total foi analisado por espetrometria de massa de cromatografia 
líquida de alta eficiência (HPLC-MS e MS / MS), permitindo a 
identificação da estrutura detalhada dos fosfolípidos, nomeadamente 
da cabeça polar e composição dos ácidos gordos. O perfil fosfolipídico 
dos macrófagos revelou ser notoriamente alterado após a infeção 
tendo-se observado uma diminuição significativa no teor de PC e um 
correspondente aumento no conteúdo de LPC apenas em células 
infectadas com promastigotas viáveis. Verificou-se ainda que a 
infeção com parasitas viáveis causou uma diminuição no teor relativo 
de ácido palmítico e um aumento na razão de ácidos gordos C18/C16. 
Os resultados de HPLC-MS reforçaram estas observações, tendo 
evidenciado alterações consideráveis nos perfis de PC, LPC, PI e PS 
entre macrófagos, macrófagos expostos a promastigotas mortos ou 
viáveis. Avaliada a transcrição de genes relacionados com o 
metabolismo lipídico verificou-se um aumento nos níveis de ARNm 
dos genes Pla2gaf, Fabp4 e Elovl2, podendo justificar deste modo os 
aumentos previamente observados nos níveis de LPC e ácidos gordos 
C18. Por fim observou-se que os promastigotas possuem considerável 
atividade enzimática PLA2 e que esta atividade poderá estar 
relacionada com a entrada do parasita na célula facilitando a infeção.   
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Visceral leishmanisis (VL) is an infectious disease caused by 
protozoan parasites of the genus Leishmania (L. infantum and L. 
donovani) that raises great concerns particularly in tropical and 
subtropical regions. Once in the host, parasites have a tropism to 
macrophages and actively subvert the immunomodulatory functions of 
these cells. Little attention was put on the effect of parasites on 
macrophage’s lipid profile. However, due to the lipids biological 
significance they can be viewed as a promising therapeutic target for 
the treatment of leishmaniasis. Therefore, the general aim of this work 
is to use a lipidomic approach to analyze the lipidomic profile of 
Leishmania infantum infected macrophages in order to elucidate the 
contribution of induced changes in the pathogenesis of this infection.  
For this purpose, the different classes of phospholipids were separated 
by TLC and quantified by a phosphorous assay and the fatty acids 
were analyzed by gas chromatography with a flame ionization detector 
(GC-FID). The total lipid extract was analyzed by high-performance 
liquid chromatography mass spectrometry (HPLC-MS and MS/MS), 
allowing the identification of the detailed structure of phospholipids, 
namely the polar head and fatty acid composition. The phospholipid 
profile of macrophages was found to be markedly altered after 
infection since a significant decrease in the content of PC and a 
corresponding increase in the content of LPC   were observed only in 
cells infected with promastigotes. Furthermore, it was also observed 
that infection with viable parasites caused a decrease in relative 
content of palmitic acid and an increase in the ratio of C18/C16 fatty 
acids. The results of HPLC-MS supported these findings and showed 
considerable changes in the profiles of PC, LPC, PI and PS between 
macrophages, macrophages exposed to viable or fixed promastigotes. 
The  evaluation of the transcription of genes related to lipid metabolism 
showed an increase in mRNA levels of genes Pla2gaf, Fabp4 and 
Elovl2  thereby supporting the previous results regarding the increase  
in LPC levels and   the increase of C18 fatty acids. Finally we found 
that promastigotes have considerable PLA2 enzyme activity and that 
this activity may be related to the parasite entry in the cell facilitating 
infection. 
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I.Introduction 
  
1. Introduction 
 Protozoan parasites of Leishmania genus are the etiological agents of human 
diseases in tropical and subtropical countries and also in more temperate regions such the 
Mediterranean basin. Multiple species of Leishmania are known to infect humans causing 
diseases that manifest as cutaneous and diffuse cutaneous leishmaniasis; mucocutaneous or 
visceral leishmaniasis (1–5). Leishmania parasites are usually transmitted by the bite of 
infected female sandflies (of the genus Phlebotomus in the Old World and the genus 
Lutzomyia in the New World), which inoculates mammalian hosts. Mammalian infection 
starts when the sandflies during a blood feeding, release the flagellated promastigote form 
of the parasite into the host. There, parasites are rapidly taken up by phagocytic cells (e.g. 
neutrophils, macrophages and immature dendritic cells) and differentiate into the 
replicative and aflagellated form termed amastigote (1,5–7). Clinical manifestations of 
leishmaniasis are dependent of the immunological status of the host, Leishmania’s specie 
and the localization of parasite in cutaneous tissues or internal organs of the host (2,8). The 
epidemiology is very diverse: 20 Leishmania species are pathogenic for humans and 30 
sandflies species are proven vectors (9). Cutaneous leishmaniasis (Cl) is caused by L. 
major, L. tropica, L. mexicana, and L. braziliensis and is characterized by a transient skin 
lesion (papule or ulcer) at the site of the insect bite. These lesions are normally painless 
and often spontaneously self-heal but when the lesions are multiple, Cl become disabling 
and disfiguring (7,9).  Diffuse Cl represents the rarest and more severe cutaneous 
manifestation and occurs in individuals with defective cell-mediated immune response, 
being very difficult to treat. The lesions caused by this infection are similar of those caused 
by lepromatous leprosy. Mucocutaneous leishmaniasis is primarily caused by L. 
braziliensis and leads to extensive destruction of naso-oropharyngeal cavities with 
disfiguring lesions, mutilation of the face and great suffering for life (7,9). Visceral 
leishmaniasis (VL), also known as kala-azar is caused by L. infantum and L. donovani and 
is often fatal if untreated. The clinical manifestations of this disease includes: fever, 
abdominal discomfort, weight loss, pallor, splenomegaly and hepatomegaly (9,10).  
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 The World Health Organization (WHO) reports that leishmaniasis is still one of the 
world’s most neglected diseases, affecting mainly the poor population of developing 
countries. It is estimated that 350 million in 80 countries people are at risk of contracting 
leishmaniasis, and that approximately 2 million new cases occur every year (8). In the last 
decade, important scientific discoveries have been made in the treatment, diagnosis and 
prevention of leishmaniasis. Thus, measures such as the control of reservoirs hosts and 
vectors, early diagnosis and an efficient treatment are crucial to handle this infection (8).  
For more than half century, pentavalent antimonials have been used as first–line 
pharmacological approaches for VL treatment, however, currently these compounds has 
been replaced by amphotericin B and miltefosine (11,12). A human anti-leishmanial 
vaccine is not available, therefore the control of the disease depends on prophylaxis and 
chemotherapy. However, the drugs available for the treatment of leishmaniasis have 
several disadvantages such as: toxicity, expensive cost and they are associated to an 
increase resistance. The development of new drugs to avoid the disadvantages referred 
above and the development of a immunoprotective vaccine is an enormous challenge due 
to the different forms of leishmaniasis, variety of parasite species, pathology and 
complexity of the  immune response associated to these infections (8). Therefore, a better 
understanding of the evasion/subversion mechanisms used by Leishmania parasites to 
escape immune system could identify new therapeutic targets and be a great help to 
develop more efficient anti-leishmanial therapies in the future. 
 
2. Leishmania life cycle 
 During its life cycle, Leishmania acquires two distinct morphological forms: the 
flagellated elongated promastigote and the aflagellated spherical amastigote (1,13,14). The 
parasite life cycle starts when sandflies belonging to the genera Phlebotomus or Lutzomyia 
take a blood meal from a mammalian host and ingest infected cells containing amastigotes.  
After the vector’s blood meal, the amastigote transforms into a promastigote in the gut of 
the insect. If the insect is an appropriate vector, the promastigote attaches to the midgut 
epithelium, otherwise the organism is eliminated by the insect’s gut. While attached to the 
gut, the promastigotes multiply by longitudinal binary fission. When the sandfly feeds 
again, the infective metacyclic promastigotes detach from the gut wall of the insect and are 
injected in the mammalian host (15,16) . The promastigotes are then phagocytized by 
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macrophages within minutes, being this internalization process facilitated by complement 
receptor-mediated recognition of surface bound C3b and/or C3bi opsonins (17). 
Promastigotes are internalized into phagosomes that fuse with lysosomes to become 
phagolysosomes, structures that in this particular infection are referred as parasitophorous 
vacuoles (PV). Once inside host cells, promastigotes suffer a morphological and structural 
transformation becoming the intracellular aflagellated form of the parasite, termed 
amastigote (figure 1). The reproduction of amastigotes in the macrophages ultimately 
ruptures cells and thus spread the infection  (1,14). Factors such as the species of 
Leishmania involved, temperature, immune system of the host, and even behavioral 
characteristics of the insect vector may determine the extent and site of infection in the 
mammalian host (14–16). A critical point for the Leishmania infection outcome is the 
interaction of parasites with macrophages, which is mainly drive by the surface molecules 
of the parasite. The surface of the Leishmania has a wide variety of important molecules 
for the evasion and survival of the parasite into phagocytic cells during the infection, 
including: lipophosphoglycan (LPG),  glycosylphosphatidylinositol (GPI)–anchored 
molecules, and glycosylinositophospholipids (GIPLS) (3,13,18). 
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Figure 1: Leishmania life cycle. Representation of the main Leishmania developmental 
stages: the sandfly stage involves the entry of the parasites into the mosquito after a blood 
meal and its transformation in the promastigote form in the midgut of the sandfly; the 
mammalian stage represents the phagocytosis of the promastigote form of the parasites by 
macrophages after the sandfly bite. In the macrophages the promastigotes will transform in 
the infectious amastigote form, thus spreading the infection. Image taken from Centers for 
Disease Control and Prevention (CDC) (19). 
 
 2.1  Leishmania virulence factors 
 As referred above, Leishmania parasites have complex strategies to survive, being 
many of them intimately related to evasion of host immune response. This ability is due to 
specific Leishmania structures that play an important role in the steps required for a 
successful infection. These structures are considered virulence factors and include among 
others, cell surface glycoconjugates such as:  lipophosphoglycans (LPGs), 
glycosilinositolphospholipids (GIPLs), GPI-anchored molecules and 
proteophosphoglycans (PPGs); secreted acid phosphatases and a vast arsenal of proteases 
(Figure 2). 
 LPG represents the major cell surface glycoconjugate of promastigotes presenting a 
conserved glycan core region of Gal(α1,6)Gal(α1,3)Galf(β1,3)[Glc(α1)-PO4]-
Man(α1,3)Man(α1,4)-GlcN(α1) linked to a 1-O-alkyl-2-lyso-phosphatidylinositol anchor. 
Structure differs however, between Leishmania species in the sugar composition and 
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sequence of branching sugars attached to the repeat units and cap structure (20–22).  In the 
last 20-30 years, enormous effort has been made in order to elucidate the role of LPG in 
Leishmania biology and virulence. Thus, LPG has been related to the inhibition of protein 
kinase C (PKC) (23), arresting of phagosome maturation (24), Leishmania parasites 
infectivity (25) and to the blockade of NADPH oxidase (26). One of the first reports on 
specific effects of LPG showed that purified L. donovani parasites turned macrophages 
unresponsive to stimulations with LPS and PKC inducers. This effect was related to the 
potent L. donovani LPG  PKC inibithory activity observed in vitro (23). Furthermore, it 
has also been reported that LPG inhibits phagosome maturation in the early stage of 
infection, allowing promastigotes to survive inside the vacuole (24) and that LPG blocks 
NADPH oxidase assembly at the phagosome membrane (26). Regarding the effect of LPG 
in the parasite infectivity, several studies showed that L. major promastigotes lacking the 
lpg1 gene thus, lacking LPG but containing normal levels of related glycoconjugates, 
caused a greatly attenuated infection. However, parasite virulence was restored when lpg1 
gene was reintroduced (25). Others parasite cells surface glycoconjugates important for its 
successful infection are the GIPLs. The basic structure of GIPLs is a Manα1-4GlcN linked 
to an alkyl-acylglycerol through a phosphatidylinositol (PI) residue. This molecule family 
is divided into type-I GIPLs, type-II GIPLs and hybrid-type GIPLs based on their fatty 
acid substitutions in the lipid anchor and monosaccharide substitutions in the glycan core 
moiety (27). Recent findings demonstrated that L.braziliensis GIPLs are components of 
complex membrane microdomains and that these molecules were necessary for the parasite 
survival and infectivity (27,28). Furthermore, it has been reported that Leishmania GIPLs 
were also very effective in inhibiting PKC activity (29). GPI-anchored molecules are also 
implicated in the parasite survival since they play a key role in cell signaling and act as 
agonists and second messengers in response to cytokines and others stimuli (27,30,31). 
GPIs share a common core consisting of ethanolamine-PO4-6Manα1-2Manα1-6Manα1-
4GlcNα1-6myo-Ino-1-PO4-lipid (32) . In addition to the glycoconjugates mentioned above, 
the PPGs also seem to be involved in the establishment of Leishmania infection. PPGs can 
take various forms going from filamentous (fPPGs), secreted (sPPGs) to membrane bound 
(mPPGs) components (33). It has been shown that sPPG isolated from L. major 
promastigote cultures interacts with murine macrophages blocking LPS-induced TNFα 
secretion (33). However, another study reported that sPPG synergistically increase IFNγ-
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stimulated NO production, suggesting a duality of sPPG in inflammatory responses (34). 
The proteophosphoglycan Promastigote Secretory Gel (PSG) also seem to favor the 
parasite infection since it participates in the Leishmania transmission by blocking the 
lumen of the insect’s anterior midgut and stomodeal valve, resulting in a regurgitation of 
metacyclic promastigotes during bloodmeal (35,36) 
 Secreted acid phosphatases (SAPs) are part of the surface of all species of 
Leishmania studied to date. Considering that SAPs have several substrates including: 
phosphorylated sugars, inositol phosphates, phosphorylated proteins and that they have a 
preference for acidic pH, it has been suggested that these enzymes modulate host 
environment and provide nutrients for the parasites (37). 
 One of the most studied Leishmania virulence factor is the metalloprotease GP63. 
This protease is involved in several strategies employed by Leishmania parasites to escape 
and subvert the immune system in order to survive and spread the infection. It was shown 
to be essential to the Leishmania´s resistance to the phagolysosome acidic and hydrolase-
rich environment (33). GP63 is a zinc-dependent metalloprotease belonging to the 
metzincin class whose members share a similar sequence motif HExxHxxGxxH, and an N- 
terminal pro-peptide. This metalloprotease is more abundant in promastigotes, however the 
absence of LPG in the amastigote surface makes that GP63 play an important role in the 
ability of amastigotes to modulate the host immunity despite its lower expression 
compared to promastigotes (33). It has been shown that proteins entrapped in liposomes 
are protected from phagolysosomal degradation when coated with purified L. mexicana 
GP63 and that this protection is lost when GP63 is destroyed by heat denaturation. 
Therefore, this data provides indirect evidence about the protective role played by GP63 
towards Leishmania amastigotes (38). Similarly, Chen and collaborators demonstrated that 
reduced GP63 levels by expression using specific antisense RNAs in L. amazonensis 
promastigotes decreases their intracellular survival rate (39). These findings suggest that 
GP63 is crucial for the protection of intracellular amastigotes from the severe environment 
of phagolysosome. Furthermore, GP63 represent the most abundant protein in Leishmania 
vesicles, which are related to death inducing stimuli (40). 
GP63 is also directly involved in the Leishmania’s capacity to exploit phosphatases 
as negative regulators of intracellular signaling cascades. It has been reported, using an L. 
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major strain deficient in GP63, that this metalloprotease was effectively responsible for the 
activation of SHP-1, PTB1B and TCPTP and that the activation of these majors protein 
tyrosine phosphatases (PTPs) was done by cleavage in their C0 terminal portion (41). The 
Leishmania virulence factor GP63 also seems to directly modulate transcription factors 
crucial to several macrophage functions, such as AP-1 and NF-κB (33,42,43). The 
transcription factor AP-1, important in IFNα-induced NO production, is formed by 
homodimers of Jun family members (c-Jun, JunB and Jun D), or heterodimers of Jun and 
Fos family members (c-Fos, Fos B, Fra 1 and Fra 2) (33). It was showed that GP63 is able 
to reach the nuclear compartment where it degrades and cleaves c-Jun and other AP-1 
subunits and therefore drastically affect the integrity of the transcription factor AP-1 during 
the early stage of Leishmania infection (44). The NF-κB is related with gene expression 
involved in a wide range of macrophage functions, being a master regulator of innate 
immune response. Gregory and colleagues reported that several Leishmania species infect 
macrophages and effectively induce the specific cleavage of the NF-κB p65RelA subunit 
in the cytoplasm (42). This cleavage was shown to be critical for the selective induction of 
cytokines and chemokines by Leishmania-infected macrophages. Furthermore, the NF-κB 
family also seems to influence the host cell cytokine production of human phagocytes 
infected by Leishmania parasites (43).  
 These findings demonstrated that the metalloprotease GP63 represents an important 
virulence factor since it’s related with several alterations of host immune cells, thus 
favoring Leishmania survival and infection progression. 
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 Figure 2: Leishmania virulence factors. A schematic representation of a promastigote 
showing cell surface glycoconjugates: LPGs, PPGs and GIPLs and virulence factors that 
are not membrane-anchored: GP63, PPGs, SAPs and CPs. Image taken from Olivier M, 
2012 (33). 
 
3.  Visceral leishmaniasis (VL) 
 Visceral leishmaniasis, also known as kala-azar, is caused by L.infantum in Europe, 
North Africa and Latin America or by L.donovani in East Africa and the Indian 
subcontinent. This infection represents the most severe form of leishmaniasis being fatal 
within two years if untreated. VL in adults is also considered an AIDS opportunistic 
disease and is characterized by a wide range of clinical symptoms caused by the parasite 
evasion into internal organs.  There are two types of VL which differ in their transmission 
characteristics: (1) zoonotic, the natural mammalian reservoir are wild animals and 
domestic animals and human infection happens by overlapping habitats; (2) anthroponotic, 
the humans are considered the natural reservoir and occur in areas of L. donovani 
transmission (8,45). The epidemiological aspects are related to environmental changes and 
individual risk factors such as migration from urban to rural areas, movement of seasonal 
workers, large-scale migrations of population for occupational reasons, deterioration in 
social and economic conditions in the poor suburbs of cities, malnutrition and overlapping 
of VL and AIDS (8,9). 
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  It is estimated that 500 000 new cases of VL occur yearly wherein 90% of them 
occur in Bangladesh, Brazil, Ethiopia, India, Nepal and Sudan. These infections are fatal   
in approximately 50.000 of the cases, being this death rate only surpassed by malaria (46). 
In the Old World (Africa, Asia and Europe), children are the most affected by endemic VL 
caused by L. infantum. However VL cases are rising among adults, mainly as an 
opportunistic co-infection in immunocompromised patients. This problem is particularly 
evident in Mediterranean countries such France, Spain, Italy and Portugal where half the 
cases are reported as coinfections, being the phenomena  partly due to the extension of 
vector habitat in consequence of climate changes.  
 In Portugal, as in other countries in southern Europe, VL was initially pediatric. 
However, it has been observed a decrease in cases affecting children and an increase in 
adult HIV patients. Between years 2000 to 2009, the Leishmaniasis Unit of the Institute of 
Hygiene and Tropical Medicine, diagnosed 173 new cases of human VL: 66 in adults and 
in immunocompromised children and 107 in immunocompromised adults. In Portugal, the 
main foci of this infection are in the region of High Douro, Mondego river valley  and the 
metropolitan area of Lisbon (47). 
 To contain the impact of this disease, control strategies are necessary and, currently 
this process involves control of reservoir and vector, early diagnosis, anti-leishmanial 
pharmacological treatment and the development of vaccines (8,45).  
 
 3.1 Clinical manifestations and Diagnosis  
 Visceral leishmaniasis is characterized by a wide range of clinical manifestations 
and can even be asymptomatic or subclinical in some cases. Following an incubation 
period that generally lasts between 2 and 6 months, VL patients present symptoms and 
signs of persistent systemic infection, including: fever, fatigue, weakness, diarrhea, loss of 
appetite and weight loss. In addition, VL causes hyperplasia of the visceral organs such as 
the spleen and liver (splenomegaly and hepatomegaly, respectively). A concomitant 
decreases in erythrocytes and leukocytes production results in anemia and 
granulocytopenia, facilitating secondary bacterial infection, especially pneumonia, 
dysentery and tuberculosis, the leading causes of death of VL patients. In a more advanced 
stage of the disease, the prothrombin production decreases and, together with 
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thrombocytopenia, may result in severe mucosal hemorrhage. The observed 
hypoalbuminaemia is associated with edema and other features of malnutrition 
(8,10,14,48). In the endemic areas of L. donovani, mainly in Sudan and less often in East 
African countries and in Indian subcontinents, after 6 months to 1 or more years of the 
treatment for VL, a complication called post-kala-azar dermal leishmaniasis (PKDL) may 
occurs. PKDL is characterized by a macular, maculo-papular or nodular rash and is highly 
infectious because the nodular lesions contain many parasites, representing this condition 
an important reservoir for anthroponotic VL (8,45). 
  In the treatment of human patients, an early diagnosis is essential because the signs 
and symptoms described above are not specific enough to differentiate VL from chronic 
malaria or other systemic infections. Thus, a laboratorial diagnosis is necessary to confirm 
the suspected VL. The detection of VL is done by parasitological diagnosis, serological 
diagnosis and antigen-detection tests (8,45,48). The parasitological diagnosis is the 
simplest, however not the more sensitive test, being based on the microscopic observation 
of the promastigote form of the parasite. The samples used in this procedure are extracted 
from tissue aspirate of the spleen or the bone marrow (49). The parasite identification can 
also be done by the detection of his DNA in blood or bone marrow aspirates by PCR. This 
procedure is more sensitive than the microscopic examination and can detect the parasite in 
asymptomatic patients however, PCR is only used in referral hospitals and research centers 
(8,48). The serological diagnosis involves techniques such as indirect fluorescence 
antibody technique (IFAT), enzyme-linked immunosorbent assay (ELISA), Western 
blotting (WB), direct agglutination test (DAT) and rK39-based immunochromatographic 
test (ICT). All of these methods provide good and accurate results however IFAT, ELISA 
and WB are not adequate for the field precarious conditions (8,50). On the other hand, 
DAT and ICT are particularly adequate for field use and represent easy and quick tests 
with low cost and reproducible results (8,51,52). Serological diagnosis have however two 
limitations: post-recovery cases are indistinguishable from active cases since specific 
antibodies remain detectable until years after the cure of the infection and a significant 
portion of healthy population in endemic areas exhibits anti-leishmanial antibodies but 
don’t have any history of VL (8,14,49). Accordingly, the serological tests must always be 
used together with a standardized clinical case definition for VL diagnosis (8). The 
antigen-detection tests are more sensitive than serological tests given they allow the 
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distinction of post-recovery cases from active cases and avoid cross-reactivity. A latex 
agglutination test to detect a heart-stable, low-relative molecular-mass carbohydrate 
antigen is a good option because this format is more adequate for application in rural areas 
where VL is endemic. The latex agglutination test is simple to use and it does not need any 
electric appliance and has a low cost (8,49).   
 3.2 Treatment 
 The treatment of VL requires complete bed rest and blood transfusions may also be 
necessary in some cases. Furthermore, chemotherapy is required and is the only treatment 
currently available for VL leishmaniasis (8,14). For more than half century, pentavalent 
antimonials have been used as first–line pharmacological approaches for VL treatment, 
however, currently these compounds has been replaced by amphotericin B and miltefosine. 
Pentavalent antimonials include chemicals such as sodium stibogluconate or meglumine 
antimonite (8,48,53). These compounds have a high efficacy, however they presents a wide 
range of toxic side effects, including: anorexia, vomiting, abdominal pain, myalgia, 
headache, lethargy, arthralgia, metallic taste, electrocardiographic changes, leukopenia, 
anemia, and thrombopenia. Uncommon, yet very serious side effects such as cardiotoxicity 
causing sudden death and pancreatitis have been also reported (8). Furthermore, the 
treatment with pentavelent antimonials is painful, invasive since it is done via 
intramuscular or intravenous routes, extensive (weeks to months), and the population of 
India and Nepal have developed resistance to these drugs (46). Other drugs intravenously 
administrated for the VL treatment are amphotericin B, its lipid formulations and 
pentamidine, which are used in countries where the population is resistant to pentavalent 
antimonials (48). More recently, with the discovery of miltefosine’s antileishmanial 
properties, oral treatment became available allowing a less invasive mode of 
administration, however this drug is teratogenic and expensive (8,45,48). Actually, a 
human anti-leishmanial vaccine is not available despite the intense investigation focused in 
this issue. The attempt for the discovery of an efficient immunizing therapy has been 
difficult due to the variety of the parasites involved in leishmnaniasis. However, after the 
recovery from the infection the immunity against the parasite is strong, thereby indicating 
that the development of a vaccine for humans would represent the ultimate therapeutic 
approach (8,45). 
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4. Host-pathogen interaction: Leishmania-macrophage 
 The outcome of Leishmania infections strongly depends on the Leishmania specie 
involved and on the immune status of the host. When the host immune system is 
compromised as in HIV patients, the infection is facilitated. It is therefore crucial the 
knowledge about the interactions of parasites with immune cells, particularly whit 
macrophages due their role in the control of the disease (8).  
 The immune response consists of two complementary arms: the humoral and 
cellular immune systems. In the control of Leishmania infections, cellular immune system 
plays a crucial role. Macrophages are cells with high phagocytic activity and moderate 
antigen-presenting abilities. These cells represent mature monocytes cells and are the 
primary effectors for Leishmania elimination, having a variety of strategies to prevent the 
survival of infecting parasites. The major pathogen-killing mechanisms of macrophages 
results from an oxidative burst due to the production of reactive nitrogen and oxygen 
species, such as superoxide (O2
–
), hydrogen peroxide (H2O2), and hydroxyl ions (–OH
–
), 
leading to the parasite degradation. The parasite internalization is facilitated by 
complement receptor-mediated recognition of surface-bound C3b and/or C3bi opsonins 
(1,54,55).  Macrophages produce many digestive enzymes, bactericidal agents and also 
interact with T helper cells (Th1 or Th2 cells), whose function is to produce cytokines like 
TNF-α, Interleukine-6, IL-8, IFN-γ and IL-12 (54,55). Another important molecule 
produced by macrophages is nitric oxide (NO), which is known to have an important role 
in the immune system and inflammation (56). However, even with the deleterious 
mechanisms described above, Leishmania parasites  establish a complex interaction with 
macrophages, avoiding their lytic mechanisms and subverting their immunostimulatory 
functions (6).  
  
 4.1 Macrophages proteins altered by Leishmania 
 To enter in host cells, metacyclic promastigote take advantage of opsonization with 
C3 and C3bi, which bind to the macrophage receptors CR1 and CR3, respectively. 
Adopting these receptors for entry, Leishmania avoid the oxidative burst since CR1 and 
CR3 don’t promote this process (57). Furthermore, CR3 inhibits the IL-12 induced cell-
mediated immunity, protecting promastigotes from deleterious effects of effector T cells 
(57,58). Additionally to  the receptors CR1 and CR3, the receptor CR4, mannose-fucose 
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receptor, FcγRI, FcγRII, C-reactive protein receptor and the receptor for advanced 
glycosylation end products (RAGEr) were shown to be involved in parasitic adhesion and 
phagocytosis (59–61). Once in the host, and in order to survive, Leishmania parasites 
actively impair several host signaling effector molecules such as cellular kinases, cellular 
phosphatases, transcription factors and cytokine production among others (Figure 3).  
 One of the kinases affected by Leishmania is Janus kinase 2 (JAK 2), a member of 
the Janus family of tyrosine kinases that play an important role in immune activation. The 
JAK signaling pathway starts when a cytokine or a growth factor binds to its receptor 
inducing a signaling cascade that ultimately results in the phosphorylation of a signal 
transducer, an activator transcription (STAT) and a transcription factor (TF) that 
consequently leading to the activation or repression of gene transcription (62). The 
alteration of the JAK signaling is advantageous for the Leishmania because the iNOS gene 
promoter has binding sites for several TFs and the parasite has the ability to block the 
JAK/STAT signaling pathway in response to the IFN-γ stimulation, thus decreasing NO 
production by macrophages (63). Nandan and Reiner reported that infection with L. 
donovani amastigotes was able to block IFN-γ-induced JAK1, JAK2, and STAT-1 
phosphorylation in PMA differentiated U-937 promonocytic cells and human monocytes 
(64). Another study demonstrated that L. donovani promastigotes rapidly activate host 
SHP-1 leading to the subsequent inhibition of IFN-γ-induced JAK2 phosphorylation (65). 
The mitogen-activated protein (MAP) kinases family also seems to be modulated by 
Leishmania parasites. The MAP kinases are serine/threonine kinases that link 
transmembrane signaling with gene transcription events and are divided in three major 
subgroups: the extracellular signal-regulated kinases (ERKs); the p38 MAP kinase and the 
c-jun amino-terminal kinases (JNKs). It has been reported that synthetic Leishmania LPGs 
activate ERK MAP kinase in macrophages which suppress the transcription of IL-12p40 
(66). Another kinase affected by the parasite is protein kinase C, which activity was shown 
to be decreased by Leishmania LPG (67).  
 Protein tyrosine phosphatases (PTPs) are proteins that have the ability to remove 
the phosphate from P –Tyr residues, reversing the effect of phosphorylation (55). Included 
in these PTPs are PTB-1, TC-PTP and SHP-1, which play an important role in Leishmania 
ability to evade host immune system evasion mechanisms (68). PTB-1 is related to the 
regulation of cytokine signaling through its interaction with JAK-2 and TYK2 and its 
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ability to dephosphorylate these kinases. As mentioned in the section 1.1.2, PTPs are 
modulated by Leishmania GP63. Activation of the protein tyrosine phosphatase TC-PTP 
represents an advantage to the parasite since it plays an important role in the negative 
regulation of JAK1, JAK3 and nuclear STAT-1 (69,70). The PTP SHP-1 is recognized as a 
negative regulator of several phosphotyrosine-dependent signaling cascades involved in 
the immune response, thus it is also important in Leishmania parasite survival. It has been 
reported that macrophages defective in SHP-1 are more efficient in limiting Leishmania 
survival and SHP-1- deficient mice display a decreased inflammation during L. donovani 
infection an observation that is associated with increased NO production (71).  
 Another target during Leishmania infection is the transcription factor NF-κB. The 
NF-κB family of transcription factors consists of five different members containing Rel 
homology domain that play crucial roles in the innate immune responses by regulating the 
expression of many pro-inflammatory mediators such as chemokines and cytokines, among 
others (72). It has been reported that mice deficient in a variety of NF-κB family members 
were susceptible to many viral, bacterial and parasitic evasion, revealing the importance of 
NF-κB in protection against infections (72). Guizani-Tabbane and collaborators showed 
that L. major amastigotes induce p50/cRel NF-κB complexes, leading to TNF-κ and IL-10 
expression (73).  
 As mentioned before, under parasitic interaction, the macrophage produces a wide 
range of cytokines such as IL-1, IL-18, IL-12, tumor necrosis factor (TNF)-α, among 
others. These molecules are responsible for a variety of biological effects in the immune 
system and can be divided in two groups: the proinflammatory (e.g., IL-1, IL-12 and IFN-
γ) and anti-inflammatory (e.g., IL-4, IL-5, IL-10 and IL-13) cytokines. Cytokines are 
mainly produced by T helper cells, being Th1 and Th2 cells connoted with production of 
proinflammatory or anti-inflammatory cytokines, respectively. Thus, the balance between 
Th1 and Th2 responses is crucial to a proper response of the immune system to an 
infection (55,74). Leishmania parasites alter this balance, favoring a Th2 response, namely 
through the production of IL-4, IL-5, IL-10 and IL-13 and inhibiting Th1 response by 
decreasing the level of pro-inflammatory cytokines IL-1, IL-12 and IFN-γ levels. It has 
been reported that infection of BMDMs with promastigotes of L. major or L. donovani 
fails to induce IL-12 production, both following infection alone and upon subsequent LPS 
or heat-killed bacterial macrophage stimulation (75). Another study reported that IL-1 and 
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TNF-α are not produced upon a 12h in vitro infection of human monocytes with 
L.donovani amastigotes (76).  
   
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3: Schematic representation of some mechanisms used by Leishmania 
parasites to evade/subvert macrophage immune functions. 
  
 4.2 Macrophages lipids altered by Leishmania 
 As mentioned in the previous section, macrophage protein alterations by 
Leishmania parasites are numerous and extensively studied. Regarding the modifications 
of the macrophage’s lipids profile by Leishmania, little is known. However due to the 
growing body of data about the immunomodulator functions of lipids they can be a 
promising therapeutic target for the treatment of the infection. Changes in lipid 
homeostasis of Leishmania-infected macrophages were already reported, namely the 
depletion of macrophage cholesterol induced by L. major, with consequences on the 
signals transmitted by CD40 engagement (77). CD40 is a co-stimulatory molecule which 
binds CD40 ligand (CD40L) and signals trough p38 and ERK1/2 mitogen activated protein 
kinases to regulate IL-12 and IL-10, respectively. In uninfected macrophages, strong CD40 
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stimulation induces the activation of p38 MAPK, thus the expression of IL-12, whereas 
weak CD40 stimulation triggers the activation of ERK1/2 signaling cascade and the 
consequent production of IL-10.  In macrophages infected with L. major, the production of 
anti-inflammatory cytokine IL-10 is enhanced, probably as the results of modulation of the 
CD40 signaling by parasites (77). A mechanism proposed to the alteration of CD40 signal 
transduction is the depletion of the macrophages membrane cholesterol caused by the 
parasite. This hypothesis results from the observation that CD40 signaling is inhibited by 
β-methyl-cyclodextrin (β-MCD)-mediated depletion of membrane cholesterol (77,78). It 
has been reported that in L. major-infected macrophages, CD40 signaling is mediated by 
distinct signalosomes, depending on the location of CD40 in cholesterol-depleted or 
cholesterol-repleted membrane fractions. The presence of CD40 in cholesterol-depleted 
favors the phosphorylation of ERK1/2 whereas the location of CD40 in cholesterol-
depleted favors the phosphorylation of p38 MAPK. It has also been reported that 
mevalonate, a cholesterol precursor, enhanced the CD40-induced phosphorylation of Lyn 
and p38 MAPK but inhibited the CD40-induced phosphorylation of Syk and Erk1/2, 
increasing the CD40-induced anti-leishmanial function in L. major-infected macrophages 
(77). However the effect of parasites on cholesterol metabolism is controversial given that 
other studies reported that L. major parasite induces cholesterol accumulation and foam 
cell formation (79). 
  Sphingolipids (SLs) in macrophages are also targets of Leishmania parasites 
during the infection (80). SLs consist in important components of the membrane and their 
metabolites such as ceramide (CER), an unmodified sphingolipid, and sphingosine-1-
phosphate control multiple processes, including cell growth, differentiation and apoptosis 
(81). Mammals require the sphingolipid synthase, SM synthase (SMS), for the biosynthesis 
of its most abundant sphingolipid, sphingomyelin (SM). This reaction occurs via the 
transfer of phosphorylcholine from phosphatidylcholine (PC) to CER to give SM. On the 
other hand, Leishmania parasites don’t synthetize SM, but rather use IPC synthase to 
catalyze the inositol phosphorylceramide (IPC), via the transfer of phosphorylinositol form 
phosphatidylinositol (PI) to CER (80,82,83). It has been reported that intramacrophage 
amastigotes synthesize the complex sphingolipid IPC de novo using precursors from the 
host and maintain this lipid species at equivalent cellular levels to promastigotes (80). 
Another study demonstrated that L. donovani stimulate host macrophages to up-regulate 
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the production of CER, a substrate for IPC synthase (84). Furthermore, a recent work has 
identified the L. major sphingomyelinases (LmjISCL), an enzyme that degrades SM, and 
showed it to be essential for pathogenicity in an animal model (85). The studies referred 
above suggest that de SLs of the host are used and essential for the infectivity and survival 
of Leishmania parasites inside macrophages. It has also been suggested that CER play a 
role in Leishmania infectivity. CER act as second messenger and participates in cell 
growth, differentiation, immunomodulation, apoptosis and induced inflammatory response. 
Gosh and collaborators demonstrated that a significant elevation of intracellular CER 
occurred in L. donovani infected macrophages (84).  Furthermore, this study revealed that 
elevation of intracellular CER was associated with down regulation of classical calcium 
dependent PKC, enhanced expression of atypical PKC-ζ isoform, decreased MAPK 
activity and NO generation. These findings suggested that ceramide helps parasite uptake 
and survival, being responsible for the down regulation of several important intracellular 
signaling cascades in infected cells (86).  
 
4.3 Other host-pathogen interactions: a lipidic point of view 
Besides the above referred studies, data regarding the effects of Leishmania 
parasites on the macrophage lipidic profile and their functional consequences remains very 
scarce. However, they are several studies reporting lipid alterations in the host cell induced 
by other microorganisms such as: dengue virus (DENV) and hepatitis C virus (HCV).  
 The dengue virus (DENV) is spread by Aedes aegyptii and Aedes albopictus 
mosquitoes and is responsible for the dengue fever. For the transmission from the mosquito 
to the human host occur, the viral replication within the vector is required. This process 
causes significant alterations into the membrane organization of the infected mosquito cells 
in order to help the virus replication and assembly. A global lipidome study of mosquito 
cells infected by DENV, using high-resolution mass spectrometry, demonstrated a 
selective enrichment of lipids involved in membranes structure as well as those that have 
potent signaling functions (87). Identified molecules include bioactive sphingolipids such 
as SM and CER, lysophospholipids (LPLs) and several intermediates such as mono- and 
diacylglycerol (DAG) and phosphatidic acid (PA). This work also showed an up regulation 
of de novo phospholipid and sphingolipid biosynthesis and that unsaturated PC is strongly 
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up regulated in DENV infected cells (87). It was shown that in the presence of C75, an 
inhibitor of the rate limiting enzyme fatty acid synthase (FAS), DENV replication is 
significantly reduced in C6/36 mosquito cells, indicating that fatty acid biosynthesis is 
important for virus viability. Furthermore, a time course experiment revealed that pre-
treatment or treatment of cells with C75 during viral adsorption reduced virus replication 
by 10 to 100 fold being the most significant effect upon addition of the drug  at 4 and 8 
hours post-infection (1000 fold). This observation strongly suggests that a post-entry step 
was affected by the inhibition of FAS (87). 
 Another pathogen that was shown to alter host cell lipid homeostasis is the 
Hepatitis C virus (HCV). HCV integrates the Flaviviridae family  and consists in a major 
cause of liver disease, being a global public health problem. It has been suggested that 
HVC alters the lipid metabolism of the host cells and that this process is crucial for the 
virus life cycle (88). A lipidome analysis during infection of Huh-7.5 (human hepatoma 
cell line) with HCV demonstrated a progressive accumulation of several 
phosphatidylcholine and phosphatidylethanolamine species of the host cell at 48 and 72 
hours post-infection relative to either the mock or UV-inactivated HCV samples. In 
contrast to the accumulation of these lipid species, it was observed a progressive decline of 
cholesterol esters, triacylglycerols, SMs, PC 35:1 and phophatidylethanolamine 38:3 
during the accumulation of extracellular infectious virions. This data suggests that these 
lipids are probably consumed during HVC assembly and secretion. The decline of some 
SMs may also result be the consequence of their utilization for the synthesis of reactive 
CER which are shown to be increased (88). 
 Although scarce, data regarding host cell lipid homeostasis modification by 
pathogens indicate that these processes could have crucial roles in installment and 
progression of infections.  Few reports approach Leishmania parasites interference with 
macrophages, lipid profile and their biological consequences. Therefore, new studies 
focused on the host-pathogen interactions at the lipidic level are required in order to 
identify novel therapeutic targets for the treatment of this infection. 
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5. Lipids: structure and biological functions 
 Lipids are essential constituents of the cell that play important roles in cellular 
functions, including: (1) the production of second messengers (e.g., araquidonic acid and 
diacylglycerol) trough enzyme reactions; (2) the capacity to delimit the cell, making it 
relatively independent of the exterior environment due to the lipid bilayer structures, (3) 
the capacity to provide the cell an appropriate hydrophobic environment for an adequate 
functionality and interactions of proteins and (4) they represent an easy and quick energetic 
storage to access. Lipids consist in a huge number of structurally and functionally distinct 
molecular species and their defining and common feature is their insolubility in water. 
Lipids can be apolar (e.g., sterol esters), neutral (e.g., triacyglycerides) and polar (e.g., 
phospholipids) (55,89). Fatty acids (FAs) represent the simplest and one of the most 
important lipid classes. Structurally, FAs are carboxylic acids with saturated or unsaturated 
hydrocarbon chains ranging from 4 to 36 carbons long (C4 to C36). FAs are precursors of 
a variety of bioactive lipid molecules. An example of a molecule modulate by FAs is the 
arachidonic acid being the precursor of eicosanoids, which function as signaling molecules 
through specific receptors and play important roles in inflammatory processes (55,89).  
 Most of cellular lipids form membrane bilayers are composed mainly by 
phospholipids, which are fundamental in biological systems and cell to cell communication 
processes. Membranes define the external boundaries of cells, regulate the molecular 
traffic across that boundary and its fluidity control, at least in part, the ligand-receptor 
interaction, endocytosis and antigen presentation (55,90). Biological membranes are 
flexible, self-sealing and selectively permeable to polar solutes. These specific properties 
of membranes are due to their constituents, namely the PLs, and their arrangement in 
bilayer in which the nonpolar regions of the lipid molecules in each layer face the core of 
the bilayer and their polar head groups face outward, interacting with the aqueous phase on 
either side. The lipids and the proteins of the cellular membrane form a fluid mosaic since 
most of the components interactions are noncovalent, being free to change constantly (55).  
PLs, the mainly constituents of cellular membranes, are amphipathic molecules having a 
head constituted by a phosphate group linked to other specific group, depending on the 
class of lipid, which is polar or hydrophilic and a tail consisting of the FA chains that are 
nonpolar or hydrophobic, both linked by a glycerol molecule. These amphipathic 
molecules allows the organize structure observe in cellular membranes.  
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 PLs are also called glycerophospholipids (GLs) and are membrane lipids in which 
two FAs are attached in ester linkage to the first and second carbons of glycerol, and a 
highly polar or charged group is attached through a phosphodiester linkage to the third 
carbon. GLs are named as derivatives of phosphatidic acid, according to the polar alcohol 
in the head group. Within the GLs are: phosphatidic acid (PA), phosphatidylethanolamine 
(PE), phosphatidylcholine (PC), phosphatidylserine (PS) and cardiolipin (CL) among 
others, differing in their polar alcohol in the head group (Figure 4). These lipids are key 
components of cellular membranes, serve as binding sites for cellular and extracellular 
proteins and their metabolites act as second messengers, being involved in proliferation 
and apoptotic cell injury (55,81).  
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Figure 4: Molecular structure of the different GLs. Adapted from Lehninger Principles 
of Biochemistry (55).  
 Sphingolipids (SLs) are composed of one molecule of the long-chain amino alcohol 
sphingosine or one of its derivatives, one molecule of a long-chain fatty acid, and a polar 
head group that is joined by a glycosidic linkage in some cases and by a phosphodiester in 
others however, unlike GLs they contain no glycerol. Belonging to this class of lipids are: 
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ceramide (CER), sphingomyelin (SM), neutral glycolipids, among others (Figure 5). SLs 
are involved in signal transduction and cell recognition (55,81). The SM together with 
cholesterol form lipid rafts: the cholesterol fills the spaces along the SM molecules 
resulting in membrane domains enriched in SM and cholesterol. These domains play an 
important role in the cell signalization since some protein components of signaling 
transduction pathways have a great affinity for these lipid rafts (91). 
  
 
 
 
Sphingolipid Name of x Formula of x 
Ceramide 
 
-----  
Sphingomyelin Phosphocholine 
 
Neutral Glycolipids 
Glucosylcerebroside 
Glucose 
 
 
Lactosylceramide 
(a globoside) 
Di,tri or 
tetrassacharide 
 
Ganglioside GM2 
Complex  
oligossacharide 
 
 
 
Figure 5: Molecular structure of the different SLs. Adapted from Lehninger Principles 
of Biochemistry (55). 
 Other lipids are also present in cells and although being present in smallest 
quantities, they play important roles such as: enzyme cofactors, electron carriers, 
hydrophobic anchors for proteins, emulsifying agents in the digestive tract, hormones, and 
intracellular messengers. For example, the eicosanoids are hormones derivatives of 
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araquidonic acid and are involved in several biological processes including: in the 
reproductive function; in the inflammation, fever and pain associated whit injury or 
disease; in blood clots, among others (55). 
 As mentioned above, lipids are structurally and functionally diversified, being 
involved in interaction with proteins thereby participating in several signaling pathways 
essential to adequate cell functioning. Thus, the identification of lipid profiling or their 
change is important to understand the living being homeostasis or disease and it requires 
complementary approaches casually called lipidomics. 
 
6. Lipid analysis: a lipidomic approach  
 Lipidomics consists in “the large-scale analysis of lipids in cells and tissues” (92). 
Lipidomic can be understood as a specialized field of metabolomics, which covers the 
study of metabolic profiles through the analysis of metabolites such as lipids and proteins 
(93). Lipidomics area extensively analyzes the different lipid classes, both qualitatively 
and quantitatively, their interaction with other molecules, their role in cellular signaling 
pathways and the changes they suffer in a pathological situation (94). Thus, there are two 
focal points that lipidomic pretends to elucidate: how to link lipid metabolites and/or lipid 
metabolic pathways in complex biological systems to individual metabolic health and how 
to interpret the changes in the lipid metabolism or in the regulation of these pathways 
linked to metabolic and inflammatory diseases from a physiological and/or pathological 
perspectives (89).  
 Lipids were target of intense research in the 60’s due to their importance in 
biological processes; however the analytical techniques available at the time were limited 
compare to the techniques for molecular biology, genomics and proteomics (95). 
Furthermore, lipids are highly diversified and complex, therefore measuring all types of 
lipids within a total lipid extract is a challenge (93). The advent of modern techniques such 
as: nuclear magnetic resonance (NMR), fluorescence spectroscopy, chromatography in 
column and mass spectrometry (MS) made lipidomics gain an increased importance and 
interest over the years. Mass spectrometry has been successfully coupled to front-end 
separation or used directly (shotgun lipidomics) to allow the identification of specific 
molecular lipids together with their quantification. This technique was one of the main 
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contributors to the growth of lipidomics (81,90).   The strategies underlying the lipidomic 
approaches involve several procedures such as: (1) the isolation of membranes 
morphologically distinct or sub fractions from tissues or cells by specific methods that take 
advantage of the high solubility of the hydrocarbon chains of lipids in organic solvents; (2) 
the extraction of lipids from membrane proteins and other components, (3) after extraction, 
lipids are separate through chromatography procedures. These procedures allow the 
identification and quantification of each lipid by MS thereby creating a lipid profile 
(Figure 6). Regarding the phospholipids, the most common extraction methods are the 
Bligh and Dyer and Folch methods and, after the separation of the PLs classes by 
chromatographic methods, the PLs content of each class can be measured by phosphorous 
assay that measures the inorganic phosphate present in the sample (81,96,97).  
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Figure 6: A schematic diagram of the overall lipidomic approache. Adapted from 
Lipidomics era: accomplishments and challenges (81). 
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Lipidomics is now considered an integral part of system biology, being an active 
topic of interest. This field has been enabled great breakthroughs since it related lipids 
imbalances to several diseases. For example, imbalances in lipid homeostasis are 
associated with Alzheimer’s, Parkinson’s, Niemann-Pick, multiple sclerosis, Huntington, 
amyotrophic lateral sclerosis, schizophrenia, bipolar disorders, epilepsy and central 
nervous system injury. Thus, lipidomics provide important insights about the stage of a 
disease and the cell homeostasis since the alterations at lipid level can elucidate alterations 
in genes and proteins and vice-versa. Lipidomics together with genomics, proteomics and 
metabolomics will provide a powerful tool to a better understanding of molecular 
mechanisms related to lipid-associated disorders, and to identify biomarkers and novel 
therapeutic targets (81). 
 
7. Aims 
 Leishmaniasis is still one of the world’s most neglected diseases, affecting in 
developing countries a significant number of people. Leishmania parasites established 
complex interactions with immune cells such as macrophages and dendritic cells, 
disrupting their normal functioning in order to survive. In the last decades, innumerous 
works have shown that these mechanisms resulted from modifications caused by parasites 
in key cellular proteins. Regarding the effects of Leishmania in host cells lipid profile, little 
is known. However, due the growing knowledge of lipid immunomodulatory functions, 
they can be viewed as a promising therapeutic target for the treatment of this infection.  
 Therefore, the general aim of this work is to analyze the variation in lipidomic 
profile of L. infantum-infected mouse macrophages in order to elucidate the contribution of 
lipidic changes to the pathogenesis of this infection. Lipid profile of infected macrophages 
will be evaluated and compared with non-infected (control) and with macrophages infected 
with killed parasites, using a lipidomic approach. After this, key proteins/enzymes 
involved in metabolic pathways related to the observed lipid alterations will be evaluated. 
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III. Material and Methods 
 
1. Materials 
The phosphatidylethanolamine (PE), phosphatidylserine (PS),phosphatidylcholine 
(PC), phosphatidylinositol (PI), phosphatidic acid (PA), sphingomyelin (SM), 
phosphatidylglycerol (PG), lysophosphatdylcholine (LPC), lysophosphatidylinositol (LPI), 
phosphatidylethanolamine (LPE), lysophosphatidic acid (LPA) and cardiolipin (CL) 
standards were purchased from Sigma-Aldrich (Madrid, Spain), triethylamine (Acros 
Organics), chloroform (HPLC grades), methanol (HPLC grades), ethanol (Panreac), 
primuline (Sigma) were used without further purification. TLC silica gel 60 plates with 
concentration zone (2.5x20cm) were purchased from Merck (Darmstadt, Germany). 
Penicillin, streptomycin, Roswell Park Memorial Institute (RPMI) 1640 and 
Dulbecco's Modified Eagle Medium (DMEM) mediums were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). Fetal Bovine Serum and TRIzol reagent were from 
Invitrogen (Paisley, UK). The protease and phosphatase inhibitor cocktails were obtained 
from Roche (Mannheim, Germany). The anti-tubulin antibody was purchased from Sigma 
Chemical Co. (St. Louis, Mo, USA), anti-COX2 antibody from Santa Cruz Biotechnology 
(Heidelberg, Germany)and anti-COX-1 from Abcam (Cambridge,UK). The alkaline 
phosphatase-linked secondary antibodies and the enhanced chemifluorescence (ECF) 
reagent were obtained from GE Healthcare (Chalfont St. Giles, UK), and the 
polyvinylidene difluoride (PVDF) membranes were from Millipore Corporation (Bedford, 
MA). iScript kit and SYBR green were obtained from BioRad (Hercules, CA, USA). 
Primers were from MWG Biotech (Ebersberg, Germany). The provenience of all other 
reagents is specified along the text. 
 
2. Culture of Macrophages  
Raw 264.7 (ATCC number: TIB-71), a mouse macrophage cell line kindly supplied 
by Dr. Otília Vieira (Center for Neuroscience and Cell Biology, University of Coimbra, 
Coimbra, Portugal) was cultured DMEM medium supplemented with 10% non-inactivated 
fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37°C in a 
humified atmosphere of 95% air and 5% CO2. 
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3. Culture of Parasites  
A cloned line of virulent L. infantum (MHOM/MA/67/ITMAP-263) was 
maintained by weakly subpassages (less than 10) in complete RPMI 1640 (RPMIc) 
supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, 
100 mg/ml streptomycin, and 2 mM HEPES (BioWhittaker). 
 
4. Lipid Extraction  
Total lipid extracts were obtained from the macrophages cell lines  in the different 
conditions using  the Bligh and Dyer method (98). HPLC solvents (chloroform and 
methanol) and milli-Q purified water were used during lipid extraction procedure. For 1 ml 
of sample in water, we added 3.75 ml chloroform /methanol 1:2 (v/v), vortexed well, and 
incubated on ice for 30 min. Then, an additional volume of 1.25 ml chloroform was added 
and finally 1.25 ml mili-Q H2O. Following vigorous vortex, samples were centrifuged at 
1000 rpm for 5 min at room temperature to obtain a two-phase system: aqueous top phase 
and organic bottom phase with chloroform from which lipids were obtained. The organic 
phase was separated into a new tube, dried in a nitrogen flow and ressuspended in 300 μl 
of chloroform making our extracts ready for the following analysis: TLC and LC-MS. 
 
5. Phosphorous Assay 
In order to quantify the total amount of PLs as well as amounts of each PL class in 
separated by TLC, a phosphorous assay was performed according to Bartlett and Lewis 
(99).To quantify the total PL extract, 10 μl the total lipid extract, after the Bligh and Dyer 
method was used, and dried with a nitrogen flow. To quantify the different classes 
separated by TLC, the spots were scraped off from the plates directly to the quantification 
tubes. Next, we added 6,5 ml of perchloric acid (70%) (Panreac) to samples which were 
then incubated in a heating block (Stuart)  45 min at 180°C. After cooling, 3.3 ml of mili-Q 
H2O, 0.5 ml of 2.5% ammonium molybdate (Riedel – de Haën) and 0.5 ml of 10% ascorbic 
acid (VWR BDH Prolabo) were added to all samples, vortexing always after the addition 
of each solution. Then, the samples were incubated for 5 min at 100°C in a water bath. 
Standards from 0.1 to 2 μg of phosphorous (P), prepared from a phosphate standard 
solution of dihydrogenphosphate dihydrated (NaH2PO4.2H2O) (Riedel – de Haën) with 100 
33 
 
μg/ml of P, underwent the same treatment as the samples. The absorbance of the samples, 
after cooling, was measured at 800 nm (Multiskan 90, Thermoscientific). In the case of 
TLC separated lipid classes, prior to spectrophotometric determination, samples were 
centrifuged 5 min at 4000 rpm to separate PLs from silica. The amount of phosphorus 
present in each sample was calculated by linear regression through the graph relating the 
amount of phosphorus present in the patterns (X-axis) with absorbance obtained from 
duplicates of various concentrations (Y-axis). The amount of phospholipid was calculated 
by multiplying the amount of result phosphorus by 25. The percentage of each PL class 
was calculated by relating the amount of PL in each TLC spot to the total amount of PL in 
the sample, thus giving the relative PL content (%) of each PL class. 
 
6. Thin Layer Chromatography 
PL classes from the total lipid extract were separated by thin layer chromatography 
(TLC) using silica gel plates with concentrating zone 2,5x20cm (Merck). Prior to 
separation, plates were washed in a methanol : chloroform mixture (1:1, v/v) and left in the 
safety hood for 20 min. Plates were then sprinkle with boric acid (2.3% m/v) (DHB 
chemicals) and dried in an oven at 100ºC during 30 min.  20 μl of phospholipid solution in 
chloroform (with a concentration of 150 μg of phospholipid per 100 μl) was applied in the 
plates. The plates were dried in a nitrogen flow and developed using the solvent mixture 
composed by chloroform, ethanol (Panreac), water and triethylamine (Merck) with a 
proportion of 30:35:7:35 (v/v/v/v). After the elution the plates were lefted in the safety 
hood until the eluent was completely dried. Lipid spots on TLC plates were observed after 
spraying a primuline solution of 50µg/100 ml (acetone : water 80:20, v/v), and visualized 
with a UV lamp (366 nm). The comparison of the spots observed with phospholipids 
standards (LPC, SM, PC, PI, PS, PE, PA, CL), run side by side in the TLC plate, allowed 
the identification of the different classes of PLs. Then, the spots were scraped off from the 
plates in order to quantify the amount of phosphorus using the phosphorous assay  
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7. Fatty Acid Quantification by Gas Chromatography with Flame Ionization  
Detector (GC-FID) 
The fatty acids profile of lipid extract  of  macrophages in each condition was 
analyzed by GC-FID with the method proposed by Pimentel and colleagues (100). Briefly, 
it uses KOH in methanol trans-methylation in order to form fatty acid methyl esters 
(FAMEs). To perform the trans-methylation, we used 40 µg of total extracts that were 
transferred to centrifuge tubes and dried in nitrogen flow. Then, it was added 1 ml of 
methyl heptadecanoate (C17:0) internal standard solution (0.75g/L in n-hexane with 1:100 
dilution). After the addition of internal standard, 0.200 ml of KOH (2M) in methanol were 
added, and the mixture was vortexed well (1-2 minutes). The mixture was then centrifuged 
at 2000 rpm during 5 minutes. The upper phase was collected into eppendorfs and the 
solvent was dried in nitrogen flow. Finally, the sample was ressuspended in 20 μl of n-
hexane, and 4 μl of this solution were injected to the chromatograph. Fatty acids were 
identified by the retention times previously determined with the same procedure with a 
mixture of standard fatty acids. The peak areas of the fatty acids were used to calculate 
their relative amount. Data acquisition and analysis was done using TotalChrom Navigator 
Software. 
The GC injection port was programmed at 250ºC and the detector at 270ºC. Oven 
temperature was programmed in three ramps, 50ºC for 3 min, 25ºC/min until 180ºC for 6 
min and 40ºC/min until 260ºC for 3 min performing 19 min totally. The carrier gas was 
hydrogen flowing at 1.7 ml/min. The column used was DB1 with 30 m, internal diameter 
of 0.250mm and 0.10 μm film thickness. 
 
8. High-Performance Liquid Chromatography (HPLC) 
In order to identify the molecular species and their changes in macrophages 
exposed to Leishmania-infantum promastigotes phospholipid classes were separated by 
LC-MS, using a HPLC system (Waters Alliance 2690) coupled to an electrospray (ESI) 
linear ion trap mass spectrometer(ThermoFinnigan, San Jose, CA, USA). The mobile 
phase A consisted of 10% water and 55% acetonitrile with 35% (v/v) of methanol. The 
mobile phase B consisted of acetonitrile 60%, methanol 40% with 10mM ammonium 
acetate. 15 μl of total lipid extract were diluted in the mobile phase A and reaction mixture 
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was introduced into a Ascentis Si HPLC Pore column (15 cm×1.0 mm, 3 μm) (Sigma-
Aldrich). The solvent gradient was programmed as follows: gradient started with 0% of A 
and linear increased to 100% of A during 20 min, and held isocratically for 35 min, 
returning, to the initial conditions in 5 min. The flow rate through the column was 16 μl/ 
min obtained using a pre-column split (Acurate, LC Packings, USA) (101). 
 
8.1 Electrospray Mass Spectrometry Conditions 
The phospholipid analysis was carried out in positive and negative modes on 
electrospray (ESI) linear ion trap mass spectrometer (ThermoFinnigan, San Jose, CA, 
USA). ESI conditions on linear ion trap mass spectrometer were as follows: electrospray 
voltage was 4.7 kV in negative mode and 5 kV in positive mode; capillary temperature was 
275ºC and the sheath gas flow was 25 units. An isolation width of 0.5 Da was used with a 
30 ms activation time for MS/MS experiments. Full scan mass spectrum and MS/MS 
spectrum were acquired with a 50 ms and 200 ms maximum ionization time, respectively. 
Normalized collision energyTM (CE) was varied between 17 and 20 (arbitrary units) for 
MS/MS. Data acquisition and treatment of results was carried out with an Xcalibur data 
System (V2.0). 
 
9. Cell Lysate Preparation and Western Blot Analysis  
To obtain the lysates for Western blot analysis, Raw cells were plated at 2x10
6 
cells/well in 6-well microplates in a final volume of 3 ml and infected with L. infantum 
promastigotes at infection ratio of 10:1 (parasite/cell) for 4 or 24 h. Cells were then washed 
in ice-cold PBS and harvested in RIPA lysis buffer (50 mM Tris–HCl (pH 8.0), 1% 
Nonidet P-40, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 2 mM EDTA and 1 
mM DTT) freshly supplemented with protease and phosphatase inhibitor cocktails (Roche, 
Mannheim, Germany). The nuclei and the insoluble cell debris were removed by 
centrifugation at 4ºC, at 12,000 g for 10 min. The post-nuclear extracts were collected and 
used as total cell lysates. Protein concentration was determined using the bicinchoninic 
acid method and the cell lysates were denatured at 95ºC, for 5 min, in sample buffer (0.125 
mM Tris pH 6.8; 2%, w/v SDS; 100 mM DTT; 10% glycerol and bromophenol blue) for 
posterior use. Western blot analysis was performed to evaluate the effect of infection on 
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the levels of COX-1 and COX-2 in macrophages. Briefly, 30 µg of protein were separated 
by electrophoresis on a 12% (v/v) SDS-polyacrylamide gel, transferred to polyvinylidene 
fluoride (PVDF) membranes and blocked with 5% (w/v) fat-free dry milk in Tris-buffered 
saline, containing 0.1% (v/v) Tween-20 (TBS-T), for 1 h at room temperature. Blots were 
then incubated overnight at 4ºC with the primary antibodies against the COX-1(1:5000) 
and COX-2 (1:5000). The membranes were then washed with TBS-T and incubated, for 1 
h at room temperature, with an alkaline phosphatase-conjugated anti-rabbit antibody 
(1:20,000). The immune complexes were detected using the Enhanced Chemifluorescence 
reagent and the membranes were scanned for blue excited fluorescence on the Thyphon 
(GE Healthcare) and analyzed using the software ImageQuant TL®. To demonstrate 
equivalent protein loading, membranes were stripped and reprobed with antibodies against 
tubulin. All the antibodies were prepared in 1% (w/v) fat-free dry milk in TBS-T. 
 
10. RNA extraction 
Cells were plated at 2 x 10
6 
cells/well in 6-well microplates in a final volume of 3 
ml and infected with L. infantum promastigotes at infection ratio of 10:1 (parasite/cell) for 
4 or 24 h. Total RNA was isolated from
 
cells with the TRIzol
®
 reagent according to the 
manufacturer's instructions. Briefly, cells were washed with ice-cold PBS harvested and 
homogenized in 1 ml of Trizol by pipetting vigorously. After addition of 200 μl of 
chloroform the samples were vortexed, incubated for 2 min at room temperature and 
centrifuged at 12,000 g, for 15 min, at 4ºC. The aqueous phase containing RNA was 
transferred to a new tube and RNA precipitated with 500 µl of isopropanol for at least 10 
min at room temperature. Following a 10 min centrifugation at 12,000 g, the pellet was 
washed with 1 ml 75% ethanol and resuspended in 100 μl 60ºC heated RNase free water.    
The RNA concentration was determined by OD260 measurement using a Nanodrop 
spectrophotometer (Wilmington, DE, USA) and quality was inspected for absence of 
degradation or genomic DNA contamination, using the Experion RNA StdSens Chips in 
the Experion
TM 
automated microfluidic electrophoresis system (BioRad Hercules, CA, 
USA). RNA was stored in RNA Storage Solution (Ambion, Foster City, CA, USA) at -
80ºC. 
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11. Real-time RT-PCR 
One microgram of total RNA was reverse transcribed using the iScript Select 
cDNA Synthesis Kit. Briefly, 2 µl of random primers and the necessary volume of RNase-
free water to complete 15 µl, were added to each RNA sample. The samples were heated at 
65ºC, for 5 min, and snap-chilled on ice for 1 min.  After this, 5 µl of a Master Mix 
containing 1 µl of iScript reverse transcriptase and 4 µl of 5x Reaction Buffer were added 
to each sample. A protocol for cDNA synthesis was run on all samples (5 min at 25ºC, 30 
min at 42ºC, 5 min at 85ºC and then put on hold at 4ºC). After the cDNA synthesis, the 
samples were diluted with RNase-free water up to a volume of 100 µl. Real-time PCR was 
performed in a 20 µl volume containing 5 µl cDNA (50 ng), 10 µl 2x Syber Green 
Supermix, 2 µl of each primer (250 nM) and 1 µl H2O PCR grade. Samples were denatured 
at 95ºC during 3 min. Subsequently, 40 cycles were run for 10 sec at 95ºC for denaturation, 
30 sec at the appropriate annealing temperature and 30 sec at 72ºC for elongation. Real-
time RT-PCR reactions were run in duplicate for each sample on a Bio-Rad My Cycler 
iQ5. Primers were designed using Beacon Designer
®
 Software v7.2, from Primier Biosoft 
International and thoroughly tested. Primer sequences and amplification efficiencies are 
given in Table 1. 
On each real-time PCR plate there was a non-template control present for each pair 
of primers analyzed. For determination of primer-pair specific efficiencies, a 4 points 
dilution series of control sample for each pair of primers was run on each experiment 
(Rasmussen, 2001). Amplification reactions were monitored using a SYBR-Green assay. 
After amplification, a threshold was set for each gene and Ct-values were calculated for all 
samples. Gene expression changes were analyzed using the built-in iQ5 Optical system 
software v2. The software enables analyzing the results with the Pfaffl method (Pfaffl, 
2001), a variation of ΔΔCT method corrected for gene-specific efficiencies, and to report 
gene expression changes as relative fold changes compared to control samples. The results 
were normalized using a reference gene, HPRT-1, determined with Genex
®
 software 
(MultiD Analyses AB) as the most stable for the treatment conditions used.  
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Table 1: Primer sequences for amplification using cDNA as template. The table shows 
the sequences of the primers used in the RT-PCR expression studies. 
Gene Primer 
Mouse SCD1  FOR 5’-GTTCACTTGTAGAATCAGAG-3’ 
Mouse SCD1  RE 5’-CATTTCCAGAGGGCTATA-3’ 
Mouse SCD2 FOR 5’-TTTGACATTTAGTCTTGGT-3’ 
Mouse SDC2 RE 5’-TATCTCTGAGTGAGGAAG-3’ 
Mouse ELOVL1  FOR 5’-TTAAACTTGGGAGAGGAA-3’ 
Mouse ELOVL1  RE 5’-ACAGTGACAGATTATTGC-3’ 
Mouse ELOVL5 FOR 5’-ACCTTCTTCATCAGTTCAA-3’ 
Mouse ELOVL5 RE 5’-TTCCCTTTCCACAGTCTA-3’ 
Mouse ELOVL2 FOR 5’-TTAGCAAGACAGAATCCA-3’ 
Mouse ELOVL2 RE 5’-TTCATTACCACATCACTAAG-3’ 
Mouse ELOVL6 FOR 5’-CTCTGTTATCCTAGTTAGTCA-3’ 
Mouse ELOVL6 RE 5’-TTATGGCTCACGAATGTT-3’ 
Mouse ELOVL3 FOR 5’-ACACAACAACGGAACACT-3’ 
Mouse ELOVL3 RE 5’-GTGGAAGAAGTGAGCGAATA-3’ 
Mouse SREBF1 FOR 5’-TGTAAGGTGTATTTGCTG-3’ 
Mouse SREBF1 RE 5’-CAAAGGAACAACTGAGAC-3’ 
Mouse FASN FOR 5’-AATAGCATCATCCTCTACTTG-3’ 
Mouse FASN RE 5’-CTCACAGTGGTCACATAC-3’ 
Mouse PLA2G4A FOR 5’-GAGTTCAGAAGACATTAGAG-3’ 
Mouse PLA2G4A RE 5’-AAGTATTACATAATCAACATCATT-3’ 
Mouse PLA2G4B FOR 5’-AGAATCTGTACTGTGTAG-3’ 
Mouse PLA2G4B RE 5’-TGTGTAGAGATTGTAAGG-3’ 
Mouse PLA2G4D FOR 5’-ATTGAATACCTCCTGTGA-3’ 
Mouse PLA2G4D RE 5’-CTGGTGAACTGAAGATTG-3’ 
Mouse PLA2G4E FOR 5’-ATCTCTTGACAGTCCTCTATG-3’ 
Mouse PLA2G4E RE 5’-CACCTCCAGTTCTTCCAT-3’ 
Mouse PLA2G4F FOR 5’-CCGTGAATGCTATCTGTT-3’ 
Mouse PLA2G4F RE 5’-CTGTTGACAAGAGGGAAA-3’ 
Mouse CXCL16 FOR 5’-AAGTGAAAGCATCTTGGA-3’ 
Mouse CXCL16 RE 5’-GAAGTCATCTGTCTGTCT-3’ 
Mouse OLR1 FOR 5’-CCTTAATGTGAATGGAATAGCA-3’ 
Mouse OLR1 RE 5’-ACTGTGGTGGAGATGTATG-3’ 
Mouse MSR1 FOR 5’-TCGTCAGTCCAGGAACAT-3’ 
Mouse MSR1 RE 5’-ATCAAGCAGTGTCATATTCAGA-3’ 
Mouse COX2 FOR 5’-ATCAGACCTTCCTTGTAT-3’ 
Mouse COX2 RE 5’-CACACTCATAGTTAAGACA-3’ 
Mouse LPCAT1 FOR 5’-GAAGTTCCTGTCTCAGAT-3’ 
Mouse LPCAT1 RE 5’-CATATTCACGAAGGTCAAT-3’ 
Mouse LPCAT2 FOR 5’-TTAACCTGCCTGTATCAA-3’ 
Mouse LPCAT2 RE 5’-TACTTAGCCTCAGTCAAC-3’ 
Mouse LPCAT3 FOR 5’-ATGGGTTACTCTATGACT-3’ 
Mouse LPCAT3 RE 5’-TGGATATAAGGCAATATGAA-3’ 
Mouse LPCAT4 FOR 5’-TTTATTGTCCTCTTTCTCC-3’ 
Mouse LPCAT4 RE 5’-ATACAGTCTTCCTCCATC-3’ 
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12. Determination of cytosolic PLA2 activity 
The activity of calcium-dependent cytosolic phospholipase A2 (cPLA2) of RAW 
cells, parasites and cells infected with parasites was determines using the Cytosolic 
Phospholipase A2 assay Kit (Abcam, Cambridge, UK) according to manufacturer 
instructions. Briefly, 5 x 10
6
 macrophages, 5 x 10
8
 promastigotes or 5 x 10
6
  24 hours-
infected cells (infection ration of 10:1 parasite/cell) where washed in PBS and  
resuspended in 200 µl ice cold Hepes buffer (50 mM Hepes, pH 7.4, 1mM EDTA). The 
cells were then sonicated five times, for 5 s at 50 µm in a Vibra Cell sonicator (Sonics & 
Material INC). Protein concentration was determined using the bicinchoninic acid method 
and 80 µg of total protein was used for each condition in the assay. 200 µl of the synthetic 
PLA2 substrate arachidonoyl thio-PC were added and the plate incubated for 60 minutes at 
room temperature. Finally, enzyme catalysis was stopped and the reaction developed by 
adding 10 μl of DTNB/EGTA to each well. After 5 min incubation, the absorbance at 405 
nm was read in a Multiskan 90, plate reader (Thermoscientific). PLA2 activity for each 
sample was calculated according the following formula: 
 
 
13. Immunocytochemistry   
RAW cells (4x10
4
) were plated in 12 wells µ-Chamber slides (IBIDI GmbH, 
Germany) and after an overnight stabilizing period were exposed for 4 hours to L.infantum 
promastigotes at a 10:1 (parasite/cell) ratio. In some experiments the phospholipase A2 
inhibitor OBAA or exogenous PLA2 where added to cells 1h before infection.  Afterwards, 
cells were washed three times with PBS, fixed with 4% paraformaldheyde for 15 min and 
washed again with PBS. The cells were then permeabilized with 0.1% (v/v) Triton-X-100, 
200 mM Glycine in PBS for 10 min at room temperature. Alexa Flúor 555 Phalloidin 
(Molecular Probes) 1:100 in PBS was added to slides during 30 min for actin staining. 
After three washing steps cells were finally exposed to nuclear label DAPI (100nM) for 2 
min and the slides analyzed with a fluorescent microscope (Nikon Corporation, Japan) at 
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630X magnification. Images were captured with a DS-Fi2 High-definition digital camera 
and analyzed in NIS-Elements Imaging Software (Nikon Corporation, Japan)  
14. Statistical Analysis 
The experiments were done independently for all conditions and the results were 
expressed as the means ± SD. Two way analysis of variance (ANOVA) with the 
Bonferroni post-hoc (for quantification of PLs and FA) was used to determine significant 
differences among samples. A value of p < 0.05 was considered significant. Statistics was 
done using PRISM® GraphPad Software. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
III. Results  
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Using a lipidomic approach, we analyzed macrophages (RAW 264.7) under 3 
different conditions: macrophages without exposure to Leishmania infantum promastigotes 
(Control); macrophages exposed to formaldeide-fixed Leishmania promastigotes (FL) and 
macrophages exposed to viable Leishmania promastigotes (VL). 
 
1. Macrophages phospholipid classes separation and quantification 
The separation of the different phospholipid (PL) classes was accomplished by thin 
layer chromatography (TLC).  The spots of each class were visualized after spraying with 
primuline, and each PL class was   identified by comparison with pure standards applied in 
the same TLC plate. This procedure allows de fractioning and identification of 
lysophosphatidylcholine (LPC), sphingomyelin (SM), phosphatidylcholine (PC), 
phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylethanolamine (PE), 
cardiolipin(CL) and ceramide (CER) classes in distinct spots (Figure 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Thin-layer chromatography of total lipid extract from macrophages 
infected with viable Leishmania parasites (VL), macrophages exposed to fixed 
parasites (FL) and uninfected cells (control). Phospholipid standards were also applied: 
LPC, SM, PC, PI, PS, PE, PG, PA, CL and CER. 
III. Results  
FL 
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After the separation of PL classes, the phospholipid content of each TLC spot was 
quantified by the phosphorous assay, thereby obtaining a relative amount of each PL class 
in the total lipid extract (Figure 8). This analysis was carried out in duplicate for each 
sample in different days and for three independent biological samples (n=3). 
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Figure 8: Major classes of phospholipids identified by TLC. In the graph is showed the 
relative phospholipid (PL) content (%) of PL classes in macrophages infected with viable 
Leishmania parasites (VL), macrophages exposed to fixed parasites (FL) and uninfected 
cell (control). Phosphate content in each spot was related to total phosphate content in the 
sample. In this case we were able to separate 7 different classes and quantified them: 
(LPC)  -Lysophosphatidylcholine; (SM) - Sphingomyelin; (PC) - Phosphatidylcholine; (PI) 
- Phosphatidylinositol; (PS)- phosphatidylserine; (PE) - Phosphatidylethanolamine; (CL) - 
Cardiolipin. *p< 0.05; **p< 0.01 comparing FL and VL versus control. The graph is 
representative of three independent biological experiments, each one performed in 
duplicate (n=3). 
 
The most abundant PL class in all conditions was PC, followed by PE. The most 
robust alteration between the tree conditions was found for the PC class, which was 
significantly decreased in cells infected with viable parasites. This decrease in PC levels 
was concomitantly followed by an increase in LPC class, which was only detected in 
macrophages exposed to viable parasites. In addition, it was possible to observe a decrease 
tendency in SM, PI, PS and CL phospholipid classes in the macrophages exposed to viable 
Leishmania parasites. Since the majority of the PL classes did not change significantly, this 
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indicates that most probably the variation of PC and LPC may be due to the action of PLA2 
(Figure 9), which converts PC in LPC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Schematic representation of the principal PL synthesis pathways. PLs are 
synthetized from PA and diacylglycerol (DAG) through different pathways and are related 
among them. Only the most important enzymes are displayed such as: SM synthase, 
Phospholipase D (PLD), Lysophosphatidylcholine acyltransferase 1 and Phospholipase A2 
(PLA2). 
 
2. Fatty acids analysis of macrophages 
In order to evaluate a possible variation in fatty acid profile in total lipid extract of 
macrophages and macrophages   exposed to promastigotes, the profile of fatty acids was 
determined by GC-FID. This procedure allowed the analysis of the fatty acids relative 
content in each condition under study: control, FL and VL (Figure 10). Analyses were also 
performed at least three times. 
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Figure 10: Relative FA content (%) in macrophages infected with viable Leishmania 
parasites (VL), macrophages infected with fixed parasites (FL) and control. We were 
able to identify 12 classes of FA: C14:0 (myristic acid) C16:1 (palmitoleic acid); C16:0  
(palmitic acid); C18:2 (linoleic acid); C18:1 (oleic acid); C18:0 (stearic acid); C20:4 
(arachidonic acid); C20:3 (eicosatrienoic acid); C20:2 (eicosadienoic acid); C20:0 
(arachidic acid); C22:6 (docosahexaenoic acid); C22:2 (docosadienoic acid), *** p < 0.01 
comparing VL versus control and FL. 
 
Results obtained with GIC-FID allowed the identification of   12 types of distinct 
FA. Those with 16 and 18 carbons were predominant. Palmitic acid (C16:0) revealed to be 
significantly decreased only in cells infected with viable parasites while linoleic acid 
(C18:2
Δ9,12
) was strongly increased in macrophages exposed to viable or fixed Leishmania 
promastigotes. 
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Figure 11: Analysis of fatty acid content. (A) Relationship between saturated (SFA) and 
unsaturated (UFA) FA; (B) between mono (MUFA) and polyunsaturated (PUFA) FA and 
(C) between FA with 16 and 18 carbons for the different conditions Control, FL and VL. 
 
We proceeded to an analysis of the relationship between saturated and unsaturated 
FA and to the C18/C16-carbon ratio for the 12 FA groups identified. We observed that the 
percentages of saturated (62%) and unsaturated FA (38%) of the control and cells exposed 
to parasites are similar. Regarding the nature of unsaturated fatty acids, we observed a 
slight increase of PUFAs in cells exposed to parasites compared to Control and FL. 
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The major differences between the three conditions were found on the length of the 
chains, the percentages of FA with 16 and 18 carbons in uninfected (control) and cells 
exposed to fixed promastigotes (FL) are similar, while in cells infected with viable parasite 
(VL) we could observe a strong increase of FA with 18 carbons and a decrease of those 
with 16 carbons. 
 
3. Analysis by HPLC-MS of macrophages phospholipid classes 
 HPLC-MS is a technique that allows the separation of PL classes and at the same 
time allows the analysis by MS and MS/MS of each class. The molecular species of each 
class were identified in order to evaluate if the changes in relative content of PL occur at 
the molecular level and to evaluate which PL class of macrophages is most affected by 
Leishmania promastigotes. PC, SM and LPC classes were analyzed by HPLC-MS and 
MS/MS in the positive mode, on the other hand, PE, PA, PS, PI e CL were analyzed by 
HPLC-MS and MS/MS in the negative mode. The chromatogram showing the elution of 
each PL class is shown in Figure 12.  
.  
 
 
 
 
 
 
 
 
 
 
Figure 12: LC-MS Chromatograms in positive and negative modes, showing where 
each PL class eluted, in the mode where they were analyzed. This chromatogram was 
obtained from the macrophages without exposure to promastigotes (Control) and is shown 
as an example since all the chromatograms had a similar profile. 
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3.1 Analysis of PC profile 
 
PCs ionize preferentially in the positive mode, forming [MH]
+ 
ions in the MS 
spectra. In Figure 13 it is shown the HPLC-MS spectra for the PC profiling obtained for 
the three conditions. The confirmation of the presence of PC molecular species, theirs most 
probable composition in fatty acyl chains and possible location in the glycerol backbone 
was accomplished by MS/MS.  The MS/MS analysis of PCs shows a characteristic product 
ion at m/z 184, another product ion due to neutral loss of polar head (loss of 183)  and ions 
due to loss of the fatty acyl chains as represented in Figure 14 (102). We were able to 
identify two groups of molecular species: diacyl-PC and alkenyl-PC (Figure 15).The most 
abundant PC species identified are summarized in Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: HPLC-MS spectra of PC class in the positive mode with formation of 
[MH]
+
 ions, in control (Control), macrophages exposed to fixed promastigotes (FL) 
and macrophages exposed to viable promastigotes (VL). Y-axis: Relative abundance 
considering the highest abundant ion as 100 %; x-axis: m/z for each ion 
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Figure 14: MS/MS spectrum of PC [M+H]
+
 at m/z 760.7 (PC C16:0/18:1) with the 
fragmentation patterns of PCs. 
 
 
 
 
 
Figure 15:General structure of diacyl and plasmenyl PC class. 
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Table 2: Identification of [MH]
+
 ions observed in the MS spectra in PC; p - an sn-1 vinyl 
ether (alkenyl- or plasmalogen) linkage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Attribution of the fatty acyl composition of each PC molecular species was done 
accordingly to the interpretation of the correspondent MS/MS spectra. C: number of carbons in the 
fatty acid chain and N: number of double bonds. 
 
 
 
 Dyacil Species 
Classe m/z [MH]+ C:N Fatty Acyl Chains 
 
706.6 30:0 14:0/16:0 
732.7 32:1 14:0/18:1 
16:0/16:1 
734.7 32:0 16:0/16:0 
14:0/18:0 
758.7 34:2 16:0/18:2 
760.7 34:1 16:0/18:1 
780.7 36:5 16:1/20:4 
782.7 36:4 18:2/18:2 
784.7 36:3 18:1/18:2 
786.7 36:2 18:0/18:2 
806.7 38:5 16:0/22:6 
806.7 38:6 18:2/20:4 
808.7 38:5 18:1/20:4 
810.7 38:4 18:0/20:4 
812.7 38:3 18:0/20:3 
814.7 38:2 18:1/20:1 
836.7 40:5 20:1/20:4 
830.7 40:8 18:2/22:6 
832.7 40:7 18:1/22:6 
 
834.7 40:6 18:0/22:6 
Alkenyl Species 
 718.7 32:0p 16:0p/16:0 
PC 
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As it can be seen in the Figure 13, the HPLC-MS spectra are similar for the three 
conditions considering the ions with higher relative abundance were the ones with m/z 
values of: 706.6; 732.7: 734.7; 760.7 and 786.7 7. However, differences were observed for 
the PC ions at m/z values of: 828.7 (PC 18:3/22:6), 830.7 (PC 18:2/22:6), which presented 
a higher relative abundance in macrophages exposed to viable Leishmania parasites (VL). 
In fact, these data are in accordance with data of fatty acyl profile, since in at m/z 830 has a 
C18:2 that was increase in the profile of macrophages infected with L. infantum.  782.7 and 
784.7, PC species with C18:2 were also increase in the infected macrophages. The spectra 
also demonstrated that the ion m/z 786.7 presented a higher relative abundance in the VL 
condition. 
3.2. Analysis of SM profile 
SM species ionize in MS in positive mode as [MH]
+
, similar to PC. Thee MS/MS 
spectra showed also the typical choline phosphate product ion at m/z 184. They can be 
easily differentiated from PC, since [MH]
+
 ions of PC appear at even m/z values, whereas 
[MH]
+
 ions of SM exhibit odd m/z values due to the presence of an additional nitrogen 
atom in SM. The major SM molecules identified are resumed in Table 3. 
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Figure 16: General structure of SM class; HPLC-MS spectra of SM class in the 
positive mode with formation of [MH]
+
 ions, in control (Control), macrophages 
exposed to fixed promastigotes (FL) and macrophages exposed to viable 
promastigotes (VL).Y-axis: Relative abundance considering the highest abundant ion as 
100 %; x-axis: m/z for each ion. *737.6 peak correspondent to the eluent. 
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Table 3: Identification of [MH]
+
 ions observed in the MS spectra in SM.  
 
 
 
 
 
 
 
 
 
 
 
Attribution of the fatty acyl composition of each SM molecular species was done 
accordingly to the interpretation of the correspondent MS/MS spectra. C: number of carbons in the 
fatty acid chain and N: number of double bonds.  
 
As it can be seen in the Figure 14, the HPLC-MS spectra are similar for the three 
conditions, except for the ion with  m/z value of 705.4, which the relative is increased in 
the macrophages exposed to viable Leishmania parasites (VL). 
 
3.3 Analysis of LPC profile 
The LPC class was only detect in TLC in macrophages exposed to viable 
Leishmania promastigotes (VL), however we were able to identify some ions of this class 
in HPLC-MS in Control and FL. LPCs were analyzed in the positive ion mode, with the 
formation of [MH]
+
 ions that were identified in the HPLC-MS spectra. The major LPC 
molecules identified are resumed in Table 4. 
 
 
  
 
Dyacil Species 
Classe m/z [MH]+ C:N Fatty Acyl Chains 
 
 
 
705.4 34:0 d18:0/16:0 
785.7 40:2 d18:1/22:1 
787.7 40:1 d18:0/22:1 
789.7 40:0 d18:0/22:0 
811.7 42:3 d18:1/24:2 
813.7 42:2 d18:1/24:1  
815.7 42:1 d18:1/24:0  
817.7 42:0 d18:0/24:0  
835.7 44:5 d18:1/26:4 
SM 
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Figure 17: General structure of LPC class; HPLC-MS of LPC class in the positive mode 
with formation of [MH]
+
 ions, in control (Control), macrophages exposed to fixed 
promastigotes (FL) and macrophages exposed to viable promastigotes (VL). Y-axis: 
Relative abundance considering the highest abundant ion as 100 %; x-axis: m/z for each 
ion.*610.2 correspondent to the eluent. 
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Table 4: Identification of [MH]
+ 
ions observed in the MS spectra in LPC.  
. 
 
 
 
 
 
Attribution of the fatty acyl composition of each LPC molecular species was done 
accordingly to the interpretation of the correspondent MS/MS spectra. C: number of carbons in the 
fatty acid chain and N: number of double bonds. 
 
The analysis of the HPLC-MS spectra in the LPC region for the different conditions 
demonstrated that the molecular species with m/z values of 568.5 and 570.4 only were 
detected in the macrophages exposed to viable Leishmania promastigotes (VL).  
The ions at m/z 590 and 592 detected in the LC-MS in the case of infected 
macrophages were identified as sodium adducts of each above described LPC species. 
 
3.4 Analysis of PE profile 
The molecular species of PE class were analyzed in the HPLC-MS in negative 
mode by the formation of [M-H]
-
 ions (Figure 18) . The most abundant PE molecules 
identified are summarized in Table 5. PE species identified included two groups of 
molecular species: diacyl-PE and alkenyl-PE (Figure 19). 
  
 
Monoacyl  Species 
Classe m/z [MH]+ C:N 
 
520.7 18:2 
568.5 22:6 
570.4 22:5 
LPC 
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Figure 18: HPLC-MS spectra of PE class in the negative mode with formation of [M-
H]
-
 ions, in control (Control), macrophages exposed to fixed promastigotes (FL) and 
macrophages exposed to viable promastigotes (VL). Y-axis: Relative abundance 
considering the highest abundant ion as 100 %; x-axis: m/z for each ion. 
 
 
 
 
Figure 19: General structure of diacyl PE and alkenyl PE. 
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Table 5: Identification of [M-H]- ions observed in the MS spectra of PE; p - an sn-1 vinyl 
ether (alkenyl- or plasmalogen) linkage..  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Attribution of the fatty acyl composition of each PE molecular species was done 
accordingly to the interpretation of the correspondent MS/MS spectra. C: number of carbons in the 
fatty acid chain and N: number of double bonds. 
 Diacyl Species 
 
 
Classe 
 
m/z [M-H]
-
 
 
C:N 
 
Fatty acyl chains 
 
714.6 34:2 16:0/18:2   
16:1/18:1 
716.6 34:1 16:0/18:1  
16:1/18:0 
740.6 36:3 18:1/18:2   
18:0/18:3 
742.6 36:2 18:1/18:1   
744.5 36:1 18:0/18:1     
746.6 36:0 18:0/18:0 
762.5 38:6 16:0/22:6 
764.5 38:5 18:0/20:5 
18:1/20:4 
766.6  18:0/20:4 
768.4 38:3 18:0/20:3 
18:1/20:2 
790.5 40:6 18:0/22:6 
792.5 40:5 18:1/22:4    
18:0/22:5 
794.5 40:4 18:0/22:4     
18:1/22:3 
796.4 40:3 18:0/22:3 
798.5 40:2 18:0/22:2 
18:1/22:1 
Alkenyl Species 
700.6 34:2p 16:0p/18:2 
16:1p/18:1 
702.5 34:1p 16:0/18:1  
 16:1/18:0 
722.6 36:4p 16:0p/20:4 
724.6 36:3p 18:1p/18:2 
726.6 36:2p 18:0p/18:2 
728.6 36:1p 18:0p/18:1 
774.5 40:6p 18:0p/22:6    
776.4 40:6p 18:1p/22:5 
PE 
59 
 
The ions with a higher relative abundance in the Control, FL and VL were the ones 
at m/z 714.6; 716.6; 742.6; 744.5; 766.6; 790.5; 792.5 and 774.5. Comparing the HPLC-
MS spectra of the three different conditions it can be seen that Leishmania promastigotes 
only caused a decrease of the relative abundance in the molecular specie at m/z value of: 
766.6 and an increase of the molecular species with m/z values of 726.6, 728.6792.5 and 
798.5. 
 
3.5 Analysis of PS profile 
PS molecular species were also analyzed by HPLC-MS in the negative mode, 
showing [M-H]
-
 ions (Figure 20). In PS mass spectra we only were able to identify diacyl-
species. PS species identified are presented in Table 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: General structure of PS class; HPLC-MS spectra of PS class in the negative 
mode with formation of [M-H]
-
 ions, in control (Control), macrophages exposed to fixed 
promastigotes (FL) and macrophages exposed to viable promastigotes (VL). Y-axis: 
Relative abundance considering the highest abundant ion as 100 %; x-axis: m/z for each 
ion. 
FL 
VL 
Control 
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Fragmentation observed in MS/MS spectra of the [PS-H]
-  
ions showed a typical 
neutral loss of 87 Da  due to loss of serine moiety, and also carboxylate ions RCOO-, that 
allowed the  identification of the PS molecular composition. As an example we show in 
Figure 21 the MS/MS spectrum of the PS molecular species with [M-H]
-
 ion  at m/z 788.5,  
where we can see that m/z 701 the  product ion [PS-H87]
-
, which corresponds to the loss of 
the serine group and the carboxylate ions at m/z 281 and 283, which corresponds to the 
C18:1 and C18:0 fatty acyl chains, allowing the identification of this PS specie as PS 
(18:0/18:1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: MS/MS spectrum of the [M-H]
-
 at m/z 788.6 correspondent to the PS 
C18:0/18:1, with the indication of the main  fragmentation patterns of PSs. 
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Table 6: Identification of [M-H]
-
 ions observed in the MS spectra of PS.  
 
 
 
 
 
 
 
 
 
Attribution of the fatty acyl composition of each PS molecular species was done 
accordingly to the interpretation of the correspondent MS/MS spectra. C: number of carbons in the 
fatty acid chain and N: number of double bonds. 
As it can be seen in the figure 20, the molecular species with higher relative 
abundance in the three conditions were 786.5; 788.5; 834.5 and 836.6. The species with 
[M-H]
-
 ions at  m/z 760.5 and 812.5 were only detected in Control and FL. On the other 
hand, the molecular species at m/z values of 834.5 PS (18:0/22:6) is significantly increased 
in VL. 
 
 
 
 
 
 
 
 
 
 
Classe 
 
m/z [M-H]- 
 
C:N 
 
Fatty acyl chains 
 
758.5 34:2 16:0/18:2 
760.5 34:1 16:0/18:1 
786.5 36:2 18:1/18:1 
788.5 36:1 18:0/18:1 
790.4 36:0 18:0/18:0 
808.5 
 
38:5 18:1/20:4 
18:2/20:3   
810.5 38:4 18:0/20:4   
18:1/20:3 
812.5 38:3 18:0/20:3 
832 40:7 18:1/22:6 
834.5 40:6 18:0/22:6 
836.6 40:5 18:0/22:5 
838.5 40:4 18:0/22:4 
PS 
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3.6 Analysis of PI profile 
PIs were analyzed also in the negative mode forming [M-H]
- 
ions  in the HPLC-MS 
spectra. The identified PI molecules are resumed in Table 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: General structure of PI class; HPLC-MS spectra of PI class in the negative 
mode with formation of [M-H]
-
 ions, in control (Control), macrophages exposed to fixed 
promastigotes (FL) and macrophages exposed to viable promastigotes (VL). Y-axis: 
Relative abundance considering the highest abundant ion as 100 %; x-axis: m/z for each 
ion. 
Control 
VL 
FL 
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Table 7: Identification of [M-H]
-
 ions observed in the MS spectra of PI.  
Classe m/z [M-H]- C:N Fatty acyl 
chains 
 
835.6 34:1 16:0/18:1    
16:1/18:0 
861.6 36:2 18:1/18:1    
18:0/18:2 
863.6 36:1 18:1/18:0 
883.6 38:5 18:1/20:4 
18:0/20:5 
885.5 38:4 18:0/20:4    
18:1/20:3 
887.6 38:3 18:0/20:3    
18:1/20:2 
889.7 38:2 18:0/20:2   
18:1/20:1 
911.5 40:5 18:0/22:5    
18:1/22:4 
 
Attribution of the fatty acyl composition of each PI molecular species was done 
accordingly to the interpretation of the correspondent MS/MS spectra. C: number of carbons in the 
fatty acid chain and N: number of double bonds. 
Comparing the HPLC-MS spectra of the three conditions, we can see that the 
molecular species with m/z values of 861.6 and 887.6 were not detected in VL. The 
molecular species with m/z values of 885.5 and 889.7 presented a lower relative abundance 
in VL.  
 
4. Expression analysis using RT-PCR 
The effects of parasites on the transcription of genes related to macrophage lipid 
metabolism were analyzed by quantitative RT-PCR (Table 8). In order to confirm and 
elucidate results obtained in TLC and GC analysis, selected genes include fatty acid 
desaturases and elongases and several enzymes related to PC-LPC interconversion such as 
phospholipase A2 and LPCAT. 
 
 
PI 
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Table 8: Gene expression profile of macrophages exposed to viable Leishmania (VL) and 
fixed Leishmania (FL) after 4 and 24 hours of exposure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The values represent the fold changes relatively to uninfected cells. When the expression 
was not detected the designation is ND. 
As shown in Table 8, several lipid metabolism-related genes were altered after 
macrophage exposure to viable or fixed parasites. From our results, the expression of 
LPCAT enzymes was not significantly modulated by exposure of cells to either viable or 
 
Gene 
Fold expression 
(4h of exposure) 
Fold expression 
(24h of  
exposure) 
 VL FL VL FL 
ABCA1 0,915 0,595 0,305 0,88 
ABCG1 1,035 0,5 0,72 0,72 
FABP4 3,05 2,65 8,71 3,65 
CD36 0,96 2,1 1,06 1,275 
CXCL16 1,2 1,3 0,99 0,75 
MSR1 1,1 1,1 1,97 1,29 
OLR1 2,3 2,3 1,93 0,86 
PLA2G4A 1,04 1,16 0,87 0,85 
PLA2G4B 0,75 0,79 0,76 0,6 
PLA2G4D ND ND ND ND 
PLA2G4E ND ND ND ND 
PLA2G4F 3,2 1,4 0,65 0,45 
FASN 0,61 0,98 0,31 0,86 
SREBF 0,73 1,41 1,14 0,7 
SCD1 0,97 1,06 1,21 0,52 
SCD2 0,85 0,59 1,13 0,7 
ELOVL1 0,78 1,05 0,74 0,63 
ELOVL2 4,7 1,47 0,86 0,22 
ELOVL3 0,93 1,31 0,43 0,76 
ELOVL5 1,41 1,52 0,76 0,88 
LPCAT1 1,1 1,8 1 0,91 
LPCAT2 1,1 1,7 1,05 0,93 
LPCAT3 1,6 1,8 0,82 0,88 
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fixed parasites. Regarding the analysis of genes coding cytosolic phospholipase A2 we 
observed that PLA2G4A, PLA2G4B and PLA2G4F were constitutively expressed, while 
PLA2G4D and PLA2G4E were barely detected in RAW cells. Among PLA2 isoforms only 
PLA2G4F revealed to be modulated by parasites: viable promastigotes caused an early 
increase in PLA2G4F mRNA and by contrast fixed parasites caused a slight decrease after 
24h (Table 8). PLA2 are enzymes that specifically recognize the sn-2 acyl bond of 
phospholipids and catalytically hydrolyze the bond releasing arachidonic acid and 
lysophospholipids. Therefore, this observation could somehow partially explain our 
previous results where higher levels of LPC were detected in cells infected with viable 
promastigotes. Additionally, we found an increased level of elongase ELOVL2 mRNA 
exclusively in viable parasite-infected cells. Once again this could partially explain the 
increased fatty acid C18/C16 ratio observed in macrophages exposed to viable 
promastigotes. Other lipid-metabolism related genes substantiality modulated by infection 
are FASN and FABP4. Transcription of fatty acid synthase (FASN) is markedly decreased 
while fatty acid binding protein 4 is increased after 24h of exposure. FASN gene encodes a 
multifunctional enzyme that catalyzes the synthesis of palmitate from acetyl-CoA and 
malonyl-CoA. Therefore these results support our previous observation in which infected 
cells presented decreased levels of palmitic acid. Finally, among analyzed genes we also 
observed after 24h exposure to viable promastigotes a marked decrease in the mRNA 
levels of cholesterol efflux transporter ABCA1 suggesting a disruption in cells ability to 
remove cholesterol from its cytoplasm. 
5. Western blot analysis of COX-1 and COX-2 
Given that we found increased levels of LPC in infected-macrophages suggesting 
and increase activity of PLA2 enzymes we hypothesize that a possible concomitant 
increase in arachidonic acid could cause changes in cyclooxygenase protein expression.     
Therefore, we analyzed by Western blot the expression of COX-1 and COX-2 proteins in 
cells exposed to viable or fixed parasites. As a positive control for COX-2 induction we 
treated macrophages with E. coli O157 lipopolysaccharide (LPS).   
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Figure 23: Effect of infection on the macrophages expression of COX-1 and COX-2. 
RAW cells (3x10
6
 per well of a 6 well plate) were exposed to viable (Inf) or fixed L. 
infantum promastigotes in a cell/parasite ratio of 1:10. Cell lysates were prepared after 4 or 
24 hours of infection. As a positive control, macrophages were stimulated with 1 µg/ml of 
LPS during the indicated periods. 30 µg of protein were loaded on a 12% SDS-
polyacrylamide gel and expression of COX-1 and COX-2 examined by Western blot using 
specific antibodies. The optical densities of the bands were obtained by scanning the 
membranes in a fluorescence scanner, and then analysed with the ImageQuant TL 
Software. The results are representative of three independent experiments. Equal protein 
loading between samples was controlled by stripping and reprobing membranes with β-
Tubulin antibody. 
 
 As it can be seen in Figure 23, exposure of macrophages to either viable or fixed 
parasites does not induce noticeable changes in COX-1 and COX-2 expression. In contrast, 
and as expected, we observed a marked increase in COX-2 protein levels in cells treated 
with LPS. 
 
6. PLA2 activity assay 
We previously showed in this work that cells infected with viable promastigotes 
present increased levels of lisophosphatidilcholine, and that this observation could be 
partially explained by an increased expression of PLA2G4F. However it is also plausible 
that infection causes an increase in the macrophage PLA2 family activity or that parasites 
possess intrinsic PLA2-like activity. To address this question we analyzed the total and 
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cytosolic PLA2 activity of macrophages, L.infantum promastigotes and cells infected with 
parasites. 
 
 
 
 
 
 
 
 
 
 
Figure 24: Evaluation of PLA2 activity in macrophages L. infantum promastigotes 
and in infected cells. 5 x 10
6
 macrophages, 5 x 10
8
 promastigotes or 5 x 10
6
 24 hours-
exposed cells (infection ration of 10:1 parasite/cell) where sonicated in ice cold hepes 
buffer and the PLA2 activity is determined for each condition as described in Material and 
Methods section. When indicated, 1 mM of bromoenol lactone was added to protein 
extract 15 min before activity determination to inhibit any secretory PLA2 activity.   
 
 We observed that RAW cells possess noticeable PLA2 activity that was not affected 
by bromoenol lactone indicating that the activity is mainly due to cytoplasmic PLA2. In 
contrast, we found that detected promastigote PLA2-like activity may result from cytosolic 
and secretory forms of the enzyme given that the signal is significantly lower in extracts 
treated with bromoenol lactone. Comparing the activities of uninfected cells, cells exposed 
to viable or fixed parasites we do not observed significant changes being however a slight 
decrease tendency detected in cells exposed to fixed parasites. These results must be 
interpreted with some caution: in extracts of parasite-exposed macrophages total protein 
concentration results from the contribution of macrophages and parasites. Given that Raw 
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cells and parasites have similar PLA2 activity and the assay is performed normalizing the 
detected activity to the total rotein concentration of each condition, it is comprehensible 
that we do not observe an increased activity in infected cells. However it is expected that in 
vivo, the putative PLA2-like enzymes of parasites will hydrolyze macrophage membrane 
phospholipids with possible consequences to infection. 
 
6. Relevance of LPC to parasites infectivity  
We observed that parasite-infected macrophages present high levels of LPC and 
that this may result from induced transcription of PLA2 and from intrinsic PLA2 activity 
of promastigotes. We next investigated the possible relevance of increased levels of LPC to 
parasite infectivity. For this we analyzed the effect in infection of OBAA, a specific PLA2 
inhibitor and of exogenous PLA2. 
Figure 25:Relevance of PLA2 activity and concomitant LPC formation to infectivity of 
L. infantum promastigotes. RAW cells (4x10
4
) were were exposed for 4 hours to 
parasites at a 10:1 (parasite/cell) ratio. In some experiments 5 mM of the phospholipase A2 
inhibitor OBAA or exogenous PLA2 where added to cells 1h before infection. 
Immunocytochemistry was performed to evaluate infection rates. Phaloidin was used to 
evidence F-actin (red) and DAPI to visualize cell nuclei and parasites kinetoplasts (blue). 
Images were obtained with a fluorescent microscope (Nikon Corporation, Japan) at 630X 
magnification. 
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We verified that inhibition of PLA2 activity by OBBA resulted in a decrease of 
infected cells and in average number of parasites per cell (Figure 25). By contrast, addition 
of exogenous PLA2 to cultures prior infection caused a slight increase in infected cells and 
a notorious increase of parasites per cell. These results strongly suggest an important role 
of LPC to the entry of parasites into the cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  IV. Discussion 
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IV. Discussion 
Innumerous studies evidence the ability of Leishmania parasites to actively subvert 
immune cells, preventing that way deleterious immune responses and allowing the 
perpetuation of infection (1,6,75). These studies are almost exclusive focused in host-
pathogens interactions at the protein level, describing mechanisms by which parasites 
interfere with key proteins in macrophages, dendritic cells and neutrophils.  Among such 
mechanisms are the cleavage of surface receptors (58), activation of phosphatases (68) and 
inactivation of key innate immune response-transcription factors (72). The information 
regarding the effects of Leishmania infection in host cells lipid content is in contrast very 
scarce. In recent years, lipids received special attention in the context of immunology, 
particularly because several works demonstrated that they possess important 
immunomodulatory functions. Therefore, we addressed in this work the effect of L. 
infantum promastigotes infection on macrophages phospholipid profile/metabolism and the 
relevance of observed changes in parasite infectivity. We observed significant alterations 
in the phospholipid content between uninfected cells and macrophages exposed to viable 
Leishmania promastigotes or formaldehyde fixed parasites. The most notorious alterations 
were observed in PC class.  Infection by viable parasites caused a marked decrease in 
macrophage PC content with a concomitant increase in LPC class. These result are in 
accordance with previous  observations of   C. Henriques and collaborators where 
significantly increased levels of LPC were found in bone marrow-derived macrophage 
infected by Leishmania amazonensis (103). We also obtained interesting differences 
between MS spectra of the three conditions for the PC and LPC classes. Regarding PC, 
species with m/z values at 828.7; 832.7 and 834.7, presented a higher relative abundance in 
cells exposed to Leishmania indicating that beside the induced decrease in total PC 
content, parasites also cause changes in the profile of the class. Although TLC analysis 
only allowed the detection of LPC in lipid extracts of viable parasites-infected cells, higher 
sensitivity of HPLC-MS technique enabled the detection of LPC species in the three 
conditions analyzed. However, and supporting TLC results, LPC species remained much 
more abundant in macrophages exposed to viable promastigotes with species with  m/z 
values at 568.5; 570.4 and 572.3 exclusively detected in this condition.  
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We showed that the observed decrease of PC and increase of LPC in promastigote-
infected macrophages was in part due to an augmented transcription of cytosolic PLA2G4F 
and/or to the direct activity of a L. infantum PLA-like enzyme. A contribution of LPC 
prevenient from parasite may however be also considered given that slight amounts of this 
lipid were detected in viable promastigotes. Although trypanosomid PLA2 enzymes have 
not yet been purified and deeply characterized our hypothesis is supported by the existence 
of Leishmania genes coding putative phospholipase A2-like proteins and by previous 
works where PLA2 degrading activities were reported in L.major (104). The authors 
suggested that the putative enzymes could be involved in the biosynthesis of procyclic 
promastigote major surface macromolecule lipophosphoglycan. Several bacteria, viruses 
and protozoan parasites such as T. cruzy have shown to possess  PLA2-like enzymes that 
act as virulence factors by modifying host cell lipids (105–107). LPC was also found in 
saliva of parasite-vectors such as Rhodnius prolixus, where it acts as an antihemostatic 
molecule during blood feeding by preventing platelet aggregation (108). Additionally, 
Mesquita R.D. and collaborators demonstrated that in Trypanosoma cruzi infection, LPC 
acts as a powerful chemoattractant for monocytes at the site of the insect bite providing a 
continuous population of cells available for infection (109). The same group also showed 
that vector´s saliva LPC cause an increase in macrophage intracellular calcium levels that 
ultimately enhance T.cruzy invasion and inhibit NO production (109). In our L.infantum-
macrophage infection model we observed that the inhibition of PLA2 activity caused a 
notorious decrease in infection ratios and in contrast the addition of exogenous PLA2 
resulted in marked increase in the number of parasites per cell. Therefore, these results 
strongly suggest that Leishmania-induced LPC formation in macrophages and the direct 
effects of intrinsic parasite-LPC may play important roles in the installment and 
progression of the infection by promoting the recruitment of new macrophages and 
facilitating the entry of parasites into cells.  
Other phospholipid classes that we found consistently altered in promastigote-
infected macrophages include PS and PI. PS is an acidic natural occurring PL, which is 
found on the cellular membrane of a great variety of organisms. It is an essential 
component of biological membranes and has important regulatory functions in cells, being 
normally maintained in the inner leaflet of the plasma membrane. The appearance of PS on 
the outer leaflet of a lipid bilayer initiate several events such as platelet aggregation, cell 
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adhesion and is an event directly connected to cell apoptosis (110,111). The analysis of PS 
by HPLC-MS showed that the species with [M-H]
- 
ions m/z at 760.5 and 812.5 were only 
detected in the control and macrophages exposed to fixed Leishmania. On the other hand, 
the [M-H]
- 
ions  at m/z  834.5; 836.6; and 838.5 were increased in infected macrophages, . 
PIs are a group of PLs widely distributed in nature and which are involved in 
secretory events and in intercellular signaling. The metabolism of inositol lipids is 
involved in the signal transduction of many hormones, neurotransmitters and growth 
factors. PI classes are precursors of important signaling molecules that modulate cell 
growth, proliferation and death (112). The analysis of PI by HPLC-MS showed that 
molecular species with m/z at 861.6 and 887.6 were not detected in infected macrophages. 
Furthermore, the molecular species with m/z of 885.5 and 889.7 presented a lower relative 
abundance in infected macrophages. These results demonstrated that Leishmania 
promastigotes possess the ability to alter the PLs classes, which are essential to membrane 
structure and functionality (55,63). 
 
We also analyzed the effect of infection in macrophage fatty acids profile and 
found that exposure to viable parasites significantly decrease cell palmitic acid (C16:0) 
content. Consistently, we observed a notorious increase in C18/C16 fatty acids ratio in the 
same condition. Finally, a slightly increased in the percentage of poly-unsaturated FAs was 
observed in cells infected with parasites comparing to the control. In conjunction, these 
results suggested an increased elongase and desaturase activity in viable promastigotes-
infected cells. Although based in indirect observations, a similar hypothesis was recently 
formulated for L.major amastigotes infected dendritic cells.  In the referred work, the 
authors performed RNA arrays and centered their analysis in lipid metabolism-related 
genes and found in infected cells two clusters of up regulated transcripts related to FA 
elongation and desaturation. To address an explanation at molecular level to our 
observations we analyzed by quantitative real-time RT-PCR the expression of genes 
coding for desaturases SCD1 and SCD2 and elongases ELOVL1, ELOVL2, ELOVL3 and 
ELOVL5. Neither the transcription of SCD1 or SCD2 was found to be modulated by 
infection, indicating that other desaturases may be involved in the observed increase of FA 
unsaturation. Regarding the elongases analyzed we found that the transcription of 
ELOVL2 was increased in macrophages exposed to viable parasites, partially justifying the 
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observed increase FA C18/C16 ratio in this condition. Another fact that could explain this 
effect and the decreased levels of palmitic acid (C16:0) registered in viable parasite 
infected-cells is the marked decrease in fatty acid synthase (FASN) transcription, an 
enzyme that catalyzes the synthesis of palmitate from acetyl-CoA and malonyl-CoA. 
Among other lipid metabolism-related genes analyzed we observed that infection 
caused considerable alterations in the levels of FABP4 and ABCA1 mRNA. Transcription 
of FABP4 was shown to be unregulated, corroborating several of our results that indicate a 
marked modulation of FA synthesis and metabolism. Fatty acid binding protein 4 is a 
cytoplasmic protein that plays a central role in fatty acid uptake, transport, and metabolism 
(113). Its transcription is mainly regulated by peroxisome proliferator activating receptor γ 
(PPARγ) and therefore is plausible to speculate that infection may activate this 
transcription factor probably through the induction of oxidized lipids. Finally, in 
accordance with results from Imen Rahbi and colleagues where decreased ABCA1 mRNA 
levels were reported in mouse bone marrow-derived macrophages infected by Leishmania 
major (114). We observed in viable parasite infected-RAW a marked and sustained 
inhibition of ABCA1 transcription. The gene ABCA1 encodes for proteins related to the 
cholesterol efflux, which is essential to membrane dynamics and signaling cascades 
dependent of lipid raft formation (115). In fact, an elegant study of Rub A. and coworkers 
demonstrated that Leishmania major infection causes a depletion in macrophages 
membrane cholesterol which directly correlates to attenuation  of CD40 transmitted signals 
(77). 
 
Overall, our results indicate that L.infantum parasites induce marked changes in 
macrophage phospholipid content either through direct activity of parasite enzymes and 
through induced changes in host cell expression of lipid metabolism related genes. Several 
of these induced changes have direct consequences in parasite infectivity and should 
therefore be explored as possible therapeutically targets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V. Conclusions 
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V. Conclusion 
The general aim of the present work was to analyze the possible changes in 
lipidomic profile of Leishmania infantum-infected mouse macrophages in order to 
elucidate the possible contribution of lipidic changes to the pathogenesis of the infection. 
Our major findings are: 
- Infection causes a significant decrease in PC class and a concomitant increase in LPC 
class; 
- This observation could be partially explained by the observed induced transcription 
of macrophage PLA2G4F and by the activity of a PLA2-like enzyme of the parasite; 
- Induced PLA2 activity and/or increased levels of LPC facilitate the entry of parasites 
into macrophages; 
- Leishmania promastigotes possess the ability to alter the molecular profile of  PI and 
PS classes, which are essential to membrane structure and functionality, and are also 
important lipid signaling molecules; 
-   Infection caused a significant decrease of macrophage palmitic acid content and 
increase of fatty acids C18/C16 ratio; 
-  This effects could be explained by the observed induced transcription of macrophage 
elongase ELOVL2 and by a strong repression of FASN; 
-   Infection caused a marked decrease in the expression of cholesterol efflux transporter   
ABACA1, suggesting a redistribution of cellular cholesterol and alterations in 
membrane dynamics.  
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